BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 859769 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C21H21N7O2/c1-15-6-7-16(30-20-19-22-10-12-26(19)13-11-23-20)14-27(15)21(29)17-4-2-3-5-18(17)28-24-8-9-25-28/h2-5,8-13,15-16H,6-7,14H2,1H3/t15-,16-/m1/s1 OQONJHBJRAWTOY-HZPDHXFCSA-N 426382 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 1 Orexin receptor type 2 Homo sapiens 35.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426382&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439380 434320721 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859770 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C21H21N7O2/c1-15-6-7-16(30-20-19-22-10-12-26(19)13-11-23-20)14-27(15)21(29)17-4-2-3-5-18(17)28-24-8-9-25-28/h2-5,8-13,15-16H,6-7,14H2,1H3/t15-,16-/m1/s1 OQONJHBJRAWTOY-HZPDHXFCSA-N 426382 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 1 Orexin/Hypocretin receptor type 1 Homo sapiens 2374 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426382&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439380 434320721 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859771 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2ccnc12 InChI=1S/C21H24N4O4S/c1-15-7-8-17(29-20-19-22-9-11-24(19)12-10-23-20)13-25(15)21(26)18-6-4-3-5-16(18)14-30(2,27)28/h3-6,9-12,15,17H,7-8,13-14H2,1-2H3/t15-,17-/m1/s1 SLCJVPQKKOFDDF-NVXWUHKLSA-N 426383 ((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)(2-((methylsulfonyl)methyl)phenyl)methanone::US10526336, Example 2::US10526336, Example 77 Orexin receptor type 2 Homo sapiens 59.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426383&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439336 434320722 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859772 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2ccnc12 InChI=1S/C21H24N4O4S/c1-15-7-8-17(29-20-19-22-9-11-24(19)12-10-23-20)13-25(15)21(26)18-6-4-3-5-16(18)14-30(2,27)28/h3-6,9-12,15,17H,7-8,13-14H2,1-2H3/t15-,17-/m1/s1 SLCJVPQKKOFDDF-NVXWUHKLSA-N 426383 ((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)(2-((methylsulfonyl)methyl)phenyl)methanone::US10526336, Example 2::US10526336, Example 77 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426383&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439336 434320722 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859773 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CC(F)(F)F)Oc1nccn2ccnc12 InChI=1S/C21H21F3N4O2/c1-14-6-7-16(30-19-18-25-8-10-27(18)11-9-26-19)13-28(14)20(29)17-5-3-2-4-15(17)12-21(22,23)24/h2-5,8-11,14,16H,6-7,12-13H2,1H3/t14-,16-/m1/s1 PRDQZAKUHDJOIQ-GDBMZVCRSA-N 426384 ((2R,5R)-5-(imidazo[1,2- alpha]pyrazin-8-yloxy)-2- methylpiperidin-1-yl)(2-(2,2,2- trifluoroethyl)phenyl)methanone::US10526336, Example 3 Orexin receptor type 2 Homo sapiens 50.4 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426384&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439799 434320723 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859774 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CC(F)(F)F)Oc1nccn2ccnc12 InChI=1S/C21H21F3N4O2/c1-14-6-7-16(30-19-18-25-8-10-27(18)11-9-26-19)13-28(14)20(29)17-5-3-2-4-15(17)12-21(22,23)24/h2-5,8-11,14,16H,6-7,12-13H2,1H3/t14-,16-/m1/s1 PRDQZAKUHDJOIQ-GDBMZVCRSA-N 426384 ((2R,5R)-5-(imidazo[1,2- alpha]pyrazin-8-yloxy)-2- methylpiperidin-1-yl)(2-(2,2,2- trifluoroethyl)phenyl)methanone::US10526336, Example 3 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426384&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439799 434320723 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859775 CCCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C22H26N4O2/c1-3-6-17-7-4-5-8-19(17)22(27)26-15-18(10-9-16(26)2)28-21-20-23-11-13-25(20)14-12-24-21/h4-5,7-8,11-14,16,18H,3,6,9-10,15H2,1-2H3/t16-,18-/m1/s1 VOEWZRYXNLDWCT-SJLPKXTDSA-N 426385 ((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)(2-propylphenyl)methanone::US10526336, Example 4::US10526336, Example 82 Orexin receptor type 2 Homo sapiens 31.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426385&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439352 434320724 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859776 CCCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C22H26N4O2/c1-3-6-17-7-4-5-8-19(17)22(27)26-15-18(10-9-16(26)2)28-21-20-23-11-13-25(20)14-12-24-21/h4-5,7-8,11-14,16,18H,3,6,9-10,15H2,1-2H3/t16-,18-/m1/s1 VOEWZRYXNLDWCT-SJLPKXTDSA-N 426385 ((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)(2-propylphenyl)methanone::US10526336, Example 4::US10526336, Example 82 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426385&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439352 434320724 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859777 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Sc1nccn2ccnc12 InChI=1S/C21H21N7OS/c1-15-6-7-16(30-20-19-22-10-12-26(19)13-11-23-20)14-27(15)21(29)17-4-2-3-5-18(17)28-24-8-9-25-28/h2-5,8-13,15-16H,6-7,14H2,1H3/t15-,16-/m1/s1 YRLBEVPYAPWLKJ-HZPDHXFCSA-N 426386 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-ylthio)-2-methylpiperidin-1-yl)methanone::US10526336, Example 5 Orexin receptor type 2 Homo sapiens 10.3 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426386&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439340 434320725 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859778 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Sc1nccn2ccnc12 InChI=1S/C21H21N7OS/c1-15-6-7-16(30-20-19-22-10-12-26(19)13-11-23-20)14-27(15)21(29)17-4-2-3-5-18(17)28-24-8-9-25-28/h2-5,8-13,15-16H,6-7,14H2,1H3/t15-,16-/m1/s1 YRLBEVPYAPWLKJ-HZPDHXFCSA-N 426386 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-ylthio)-2-methylpiperidin-1-yl)methanone::US10526336, Example 5 Orexin/Hypocretin receptor type 1 Homo sapiens 2389 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426386&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439340 434320725 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859779 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H23N7O2/c1-15-13-27-12-11-23-21(20(27)26-15)31-17-8-7-16(2)28(14-17)22(30)18-5-3-4-6-19(18)29-24-9-10-25-29/h3-6,9-13,16-17H,7-8,14H2,1-2H3/t16-,17-/m1/s1 KFVCHBHKPYGOHS-IAGOWNOFSA-N 426387 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 11::US10526336, Example 6 Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426387&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439374 434320726 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859780 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H23N7O2/c1-15-13-27-12-11-23-21(20(27)26-15)31-17-8-7-16(2)28(14-17)22(30)18-5-3-4-6-19(18)29-24-9-10-25-29/h3-6,9-13,16-17H,7-8,14H2,1-2H3/t16-,17-/m1/s1 KFVCHBHKPYGOHS-IAGOWNOFSA-N 426387 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 11::US10526336, Example 6 Orexin/Hypocretin receptor type 1 Homo sapiens 1349 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426387&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439374 434320726 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859781 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C20H21N7O2S/c1-13-11-25-9-8-21-18(17(25)24-13)29-15-4-3-14(2)26(12-15)19(28)16-5-10-30-20(16)27-22-6-7-23-27/h5-11,14-15H,3-4,12H2,1-2H3/t14-,15-/m1/s1 REICNUFBPPXMCV-HUUCEWRRSA-N 426388 (2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl)((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 7 Orexin receptor type 2 Homo sapiens 27.4 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426388&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439349 434320727 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859782 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C20H21N7O2S/c1-13-11-25-9-8-21-18(17(25)24-13)29-15-4-3-14(2)26(12-15)19(28)16-5-10-30-20(16)27-22-6-7-23-27/h5-11,14-15H,3-4,12H2,1-2H3/t14-,15-/m1/s1 REICNUFBPPXMCV-HUUCEWRRSA-N 426388 (2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl)((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 7 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426388&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439349 434320727 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859783 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C20H21N7O2S/c1-13-9-25-8-7-21-19(18(25)24-13)29-15-4-3-14(2)26(10-15)20(28)16-11-30-12-17(16)27-22-5-6-23-27/h5-9,11-12,14-15H,3-4,10H2,1-2H3/t14-,15-/m1/s1 LIQARBFRBHCGLD-HUUCEWRRSA-N 426389 (4-(2H-1,2,3-triazol-2-yl)thiophen-3- yl)((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)methanone::US10526336, Example 8 Orexin receptor type 2 Homo sapiens 39.1 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426389&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439855 434320728 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859784 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C20H21N7O2S/c1-13-9-25-8-7-21-19(18(25)24-13)29-15-4-3-14(2)26(10-15)20(28)16-11-30-12-17(16)27-22-5-6-23-27/h5-9,11-12,14-15H,3-4,10H2,1-2H3/t14-,15-/m1/s1 LIQARBFRBHCGLD-HUUCEWRRSA-N 426389 (4-(2H-1,2,3-triazol-2-yl)thiophen-3- yl)((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)methanone::US10526336, Example 8 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426389&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439855 434320728 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859785 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1nccn2cc(C)nc12 InChI=1S/C24H25N5O2/c1-16-13-28-12-11-26-22(21(28)27-16)31-18-8-7-17(2)29(14-18)23(30)19-5-3-4-6-20(19)24(15-25)9-10-24/h3-6,11-13,17-18H,7-10,14H2,1-2H3/t17-,18-/m1/s1 SXVFMYAMZHNWPN-QZTJIDSGSA-N 426390 1-(2-((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha]pyrazin-8- yl)oxy)piperidine-1- carbonyl)phenyl)cyclopropanecarbonitrile::US10526336, Example 9 Orexin receptor type 2 Homo sapiens 13.2 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426390&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439882 434320729 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859786 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1nccn2cc(C)nc12 InChI=1S/C24H25N5O2/c1-16-13-28-12-11-26-22(21(28)27-16)31-18-8-7-17(2)29(14-18)23(30)19-5-3-4-6-20(19)24(15-25)9-10-24/h3-6,11-13,17-18H,7-10,14H2,1-2H3/t17-,18-/m1/s1 SXVFMYAMZHNWPN-QZTJIDSGSA-N 426390 1-(2-((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha]pyrazin-8- yl)oxy)piperidine-1- carbonyl)phenyl)cyclopropanecarbonitrile::US10526336, Example 9 Orexin/Hypocretin receptor type 1 Homo sapiens 6697 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426390&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439882 434320729 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859787 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H22FN7O2/c1-14-12-28-10-9-24-21(20(28)27-14)32-17-5-3-15(2)29(13-17)22(31)18-6-4-16(23)11-19(18)30-25-7-8-26-30/h4,6-12,15,17H,3,5,13H2,1-2H3/t15-,17-/m1/s1 MMSDZCRKMCUVLM-NVXWUHKLSA-N 426391 (4-fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)methanone::US10526336, Example 10 Orexin receptor type 2 Homo sapiens 31.2 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426391&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439792 434320730 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859788 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H22FN7O2/c1-14-12-28-10-9-24-21(20(28)27-14)32-17-5-3-15(2)29(13-17)22(31)18-6-4-16(23)11-19(18)30-25-7-8-26-30/h4,6-12,15,17H,3,5,13H2,1-2H3/t15-,17-/m1/s1 MMSDZCRKMCUVLM-NVXWUHKLSA-N 426391 (4-fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)methanone::US10526336, Example 10 Orexin/Hypocretin receptor type 1 Homo sapiens 2131 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426391&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439792 434320730 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859789 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H23N7O2/c1-15-13-27-12-11-23-21(20(27)26-15)31-17-8-7-16(2)28(14-17)22(30)18-5-3-4-6-19(18)29-24-9-10-25-29/h3-6,9-13,16-17H,7-8,14H2,1-2H3/t16-,17-/m1/s1 KFVCHBHKPYGOHS-IAGOWNOFSA-N 426387 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 11::US10526336, Example 6 Orexin receptor type 2 Homo sapiens 22.2 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426387&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439374 434320726 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859790 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H23N7O2/c1-15-13-27-12-11-23-21(20(27)26-15)31-17-8-7-16(2)28(14-17)22(30)18-5-3-4-6-19(18)29-24-9-10-25-29/h3-6,9-13,16-17H,7-8,14H2,1-2H3/t16-,17-/m1/s1 KFVCHBHKPYGOHS-IAGOWNOFSA-N 426387 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 11::US10526336, Example 6 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426387&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439374 434320726 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859791 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2cc(C)nc12 InChI=1S/C22H26N4O4S/c1-15-12-25-11-10-23-21(20(25)24-15)30-18-9-8-16(2)26(13-18)22(27)19-7-5-4-6-17(19)14-31(3,28)29/h4-7,10-12,16,18H,8-9,13-14H2,1-3H3/t16-,18-/m1/s1 SJDFLHFELXXPDH-SJLPKXTDSA-N 426393 ((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)(2- ((methylsulfonyl)methyl)phenyl)methanone::US10526336, Example 12 Orexin receptor type 2 Homo sapiens 46.2 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426393&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439852 434320731 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859792 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2cc(C)nc12 InChI=1S/C22H26N4O4S/c1-15-12-25-11-10-23-21(20(25)24-15)30-18-9-8-16(2)26(13-18)22(27)19-7-5-4-6-17(19)14-31(3,28)29/h4-7,10-12,16,18H,8-9,13-14H2,1-3H3/t16-,18-/m1/s1 SJDFLHFELXXPDH-SJLPKXTDSA-N 426393 ((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)(2- ((methylsulfonyl)methyl)phenyl)methanone::US10526336, Example 12 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426393&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439852 434320731 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859793 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H22N6O2S/c1-14-10-27-9-8-25-21(20(27)26-14)30-16-5-4-15(2)28(11-16)22(29)18-13-31-12-17(18)19-23-6-3-7-24-19/h3,6-10,12-13,15-16H,4-5,11H2,1-2H3/t15-,16-/m1/s1 XRRDRLMCAFXUSS-HZPDHXFCSA-N 426394 ((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)(4-(pyrimidin-2-yl)thiophen-3-yl)methanone::US10526336, Example 13 Orexin receptor type 2 Homo sapiens 63.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426394&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439364 434320732 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859794 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H22N6O2S/c1-14-10-27-9-8-25-21(20(27)26-14)30-16-5-4-15(2)28(11-16)22(29)18-13-31-12-17(18)19-23-6-3-7-24-19/h3,6-10,12-13,15-16H,4-5,11H2,1-2H3/t15-,16-/m1/s1 XRRDRLMCAFXUSS-HZPDHXFCSA-N 426394 ((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)(4-(pyrimidin-2-yl)thiophen-3-yl)methanone::US10526336, Example 13 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426394&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439364 434320732 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859795 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H22N6O2S/c1-14-12-27-10-9-25-21(20(27)26-14)30-16-5-4-15(2)28(13-16)22(29)17-6-11-31-18(17)19-23-7-3-8-24-19/h3,6-12,15-16H,4-5,13H2,1-2H3/t15-,16-/m1/s1 OYHCTRXCMGAVDK-HZPDHXFCSA-N 426395 ((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha] pyrazin-8-yl) oxy)piperidin-1-yl) (2-(pyrimidin-2- yl)thiophen-3- yl)methanone::US10526336, Example 14 Orexin receptor type 2 Homo sapiens 36.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426395&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439885 434320733 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859796 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H22N6O2S/c1-14-12-27-10-9-25-21(20(27)26-14)30-16-5-4-15(2)28(13-16)22(29)17-6-11-31-18(17)19-23-7-3-8-24-19/h3,6-12,15-16H,4-5,13H2,1-2H3/t15-,16-/m1/s1 OYHCTRXCMGAVDK-HZPDHXFCSA-N 426395 ((2R,5R)-2-methyl-5-((2- methylimidazo[1,2-alpha] pyrazin-8-yl) oxy)piperidin-1-yl) (2-(pyrimidin-2- yl)thiophen-3- yl)methanone::US10526336, Example 14 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426395&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439885 434320733 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859797 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)F)Oc1nccn2cc(C)nc12 InChI=1S/C21H23F2N5O3/c1-13-10-27-9-8-25-20(18(27)26-13)31-15-6-5-14(2)28(11-15)21(29)16-4-3-7-24-19(16)30-12-17(22)23/h3-4,7-10,14-15,17H,5-6,11-12H2,1-2H3/t14-,15-/m1/s1 JZRBAXXJGDJYKQ-HUUCEWRRSA-N 426396 US10526336, Example 15 Orexin receptor type 2 Homo sapiens 41.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426396&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439335 434320734 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859798 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)F)Oc1nccn2cc(C)nc12 InChI=1S/C21H23F2N5O3/c1-13-10-27-9-8-25-20(18(27)26-13)31-15-6-5-14(2)28(11-15)21(29)16-4-3-7-24-19(16)30-12-17(22)23/h3-4,7-10,14-15,17H,5-6,11-12H2,1-2H3/t14-,15-/m1/s1 JZRBAXXJGDJYKQ-HUUCEWRRSA-N 426396 US10526336, Example 15 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426396&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439335 434320734 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859799 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)Oc1nccn2cc(C)nc12 InChI=1S/C21H22F3N5O3/c1-13-10-28-9-8-26-19(17(28)27-13)32-15-6-5-14(2)29(11-15)20(30)16-4-3-7-25-18(16)31-12-21(22,23)24/h3-4,7-10,14-15H,5-6,11-12H2,1-2H3/t14-,15-/m1/s1 HPRZHGRPPJOIQY-HUUCEWRRSA-N 426397 ((2R,5R)-2-methyl-5- ((2-methylimidazo [1,2-alpha]pyrazin-8-yl) oxy)piperidin-1-yl) (2-(2,2,2- trifluoroethoxy) pyridin- 3-yl)methanone::US10526336, Example 16 Orexin receptor type 2 Homo sapiens 33.5 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426397&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439838 434320735 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859800 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)Oc1nccn2cc(C)nc12 InChI=1S/C21H22F3N5O3/c1-13-10-28-9-8-26-19(17(28)27-13)32-15-6-5-14(2)29(11-15)20(30)16-4-3-7-25-18(16)31-12-21(22,23)24/h3-4,7-10,14-15H,5-6,11-12H2,1-2H3/t14-,15-/m1/s1 HPRZHGRPPJOIQY-HUUCEWRRSA-N 426397 ((2R,5R)-2-methyl-5- ((2-methylimidazo [1,2-alpha]pyrazin-8-yl) oxy)piperidin-1-yl) (2-(2,2,2- trifluoroethoxy) pyridin- 3-yl)methanone::US10526336, Example 16 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426397&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439838 434320735 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859801 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-c1ccccc1)Oc1nccn2cc(C)nc12 InChI=1S/C25H25N5O2/c1-17-15-29-14-13-27-24(23(29)28-17)32-20-11-10-18(2)30(16-20)25(31)21-9-6-12-26-22(21)19-7-4-3-5-8-19/h3-9,12-15,18,20H,10-11,16H2,1-2H3/t18-,20-/m1/s1 WOUFWOXTAOEIOV-UYAOXDASSA-N 426398 ((2R,5R)-2-methyl-5- ((2-methylimidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl) (2-phenylpyridin- 3-yl)methanone::US10526336, Example 17 Orexin receptor type 2 Homo sapiens 68.4 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426398&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439819 434320736 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859802 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-c1ccccc1)Oc1nccn2cc(C)nc12 InChI=1S/C25H25N5O2/c1-17-15-29-14-13-27-24(23(29)28-17)32-20-11-10-18(2)30(16-20)25(31)21-9-6-12-26-22(21)19-7-4-3-5-8-19/h3-9,12-15,18,20H,10-11,16H2,1-2H3/t18-,20-/m1/s1 WOUFWOXTAOEIOV-UYAOXDASSA-N 426398 ((2R,5R)-2-methyl-5- ((2-methylimidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl) (2-phenylpyridin- 3-yl)methanone::US10526336, Example 17 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426398&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439819 434320736 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859803 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-n1cccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H23N7O2/c1-15-13-27-12-10-24-21(20(27)26-15)31-17-7-6-16(2)28(14-17)22(30)18-5-3-8-23-19(18)29-11-4-9-25-29/h3-5,8-13,16-17H,6-7,14H2,1-2H3/t16-,17-/m1/s1 PWBLYEXCSDJREV-IAGOWNOFSA-N 426399 (2-(1H-pyrazol-1- yl)pyridin-3-yl) ((2R,5R)- 2-methyl-5-((2- methylimidazo[1,2-alpha] pyrazin-8- yl)oxy)piperidin-1- yl)methanone::US10526336, Example 18 Orexin receptor type 2 Homo sapiens 58.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426399&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439810 434320737 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859804 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-n1cccn1)Oc1nccn2cc(C)nc12 InChI=1S/C22H23N7O2/c1-15-13-27-12-10-24-21(20(27)26-15)31-17-7-6-16(2)28(14-17)22(30)18-5-3-8-23-19(18)29-11-4-9-25-29/h3-5,8-13,16-17H,6-7,14H2,1-2H3/t16-,17-/m1/s1 PWBLYEXCSDJREV-IAGOWNOFSA-N 426399 (2-(1H-pyrazol-1- yl)pyridin-3-yl) ((2R,5R)- 2-methyl-5-((2- methylimidazo[1,2-alpha] pyrazin-8- yl)oxy)piperidin-1- yl)methanone::US10526336, Example 18 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426399&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439810 434320737 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859805 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccn2cc(C)nc12 InChI=1S/C22H24N8O/c1-15-13-28-12-11-23-20(21(28)26-15)27-17-8-7-16(2)29(14-17)22(31)18-5-3-4-6-19(18)30-24-9-10-25-30/h3-6,9-13,16-17H,7-8,14H2,1-2H3,(H,23,27)/t16-,17-/m1/s1 YNXOHVSBXCHJEY-IAGOWNOFSA-N 426400 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)amino)piperidin-1-yl)methanone::US10526336, Example 19 Orexin receptor type 2 Homo sapiens 50.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426400&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439339 434320738 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859806 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccn2cc(C)nc12 InChI=1S/C22H24N8O/c1-15-13-28-12-11-23-20(21(28)26-15)27-17-8-7-16(2)29(14-17)22(31)18-5-3-4-6-19(18)30-24-9-10-25-30/h3-6,9-13,16-17H,7-8,14H2,1-2H3,(H,23,27)/t16-,17-/m1/s1 YNXOHVSBXCHJEY-IAGOWNOFSA-N 426400 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methylimidazo[1,2-a]pyrazin-8-yl)amino)piperidin-1-yl)methanone::US10526336, Example 19 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426400&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439339 434320738 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859807 CC(C)c1cn2ccnc(O[C@@H]3CC[C@@H](C)N(C3)C(=O)c3ccccc3-n3nccn3)c2n1 InChI=1S/C24H27N7O2/c1-16(2)20-15-29-13-12-25-23(22(29)28-20)33-18-9-8-17(3)30(14-18)24(32)19-6-4-5-7-21(19)31-26-10-11-27-31/h4-7,10-13,15-18H,8-9,14H2,1-3H3/t17-,18-/m1/s1 ZMVNWSDPVGIMBL-QZTJIDSGSA-N 426401 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((2-isopropylimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 20 Orexin receptor type 2 Homo sapiens 49.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426401&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439345 434320739 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859808 CC(C)c1cn2ccnc(O[C@@H]3CC[C@@H](C)N(C3)C(=O)c3ccccc3-n3nccn3)c2n1 InChI=1S/C24H27N7O2/c1-16(2)20-15-29-13-12-25-23(22(29)28-20)33-18-9-8-17(3)30(14-18)24(32)19-6-4-5-7-21(19)31-26-10-11-27-31/h4-7,10-13,15-18H,8-9,14H2,1-3H3/t17-,18-/m1/s1 ZMVNWSDPVGIMBL-QZTJIDSGSA-N 426401 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((2-isopropylimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 20 Orexin/Hypocretin receptor type 1 Homo sapiens 3010 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426401&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439345 434320739 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859809 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(nc12)C(F)(F)F InChI=1S/C22H20F3N7O2/c1-14-6-7-15(34-20-19-29-18(22(23,24)25)13-30(19)11-10-26-20)12-31(14)21(33)16-4-2-3-5-17(16)32-27-8-9-28-32/h2-5,8-11,13-15H,6-7,12H2,1H3/t14-,15-/m1/s1 ZYXPVVNSZVQRSO-HUUCEWRRSA-N 426402 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 21 Orexin receptor type 2 Homo sapiens 63.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426402&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439359 434320740 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859810 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(nc12)C(F)(F)F InChI=1S/C22H20F3N7O2/c1-14-6-7-15(34-20-19-29-18(22(23,24)25)13-30(19)11-10-26-20)12-31(14)21(33)16-4-2-3-5-17(16)32-27-8-9-28-32/h2-5,8-11,13-15H,6-7,12H2,1H3/t14-,15-/m1/s1 ZYXPVVNSZVQRSO-HUUCEWRRSA-N 426402 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 21 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426402&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439359 434320740 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859811 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccn2cc(nc12)C(F)(F)F InChI=1S/C22H21F3N8O/c1-14-6-7-15(29-19-20-30-18(22(23,24)25)13-31(20)11-10-26-19)12-32(14)21(34)16-4-2-3-5-17(16)33-27-8-9-28-33/h2-5,8-11,13-15H,6-7,12H2,1H3,(H,26,29)/t14-,15-/m1/s1 YEHNRBRTNOJFGZ-HUUCEWRRSA-N 426403 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-yl)amino)piperidin-1-yl)methanone::US10526336, Example 22 Orexin receptor type 2 Homo sapiens 45.4 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426403&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439383 434320741 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859812 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccn2cc(nc12)C(F)(F)F InChI=1S/C22H21F3N8O/c1-14-6-7-15(29-19-20-30-18(22(23,24)25)13-31(20)11-10-26-19)12-32(14)21(34)16-4-2-3-5-17(16)33-27-8-9-28-33/h2-5,8-11,13-15H,6-7,12H2,1H3,(H,26,29)/t14-,15-/m1/s1 YEHNRBRTNOJFGZ-HUUCEWRRSA-N 426403 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-yl)amino)piperidin-1-yl)methanone::US10526336, Example 22 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426403&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439383 434320741 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859813 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2cc(nc12)C(F)(F)F InChI=1S/C20H18F3N7O2S/c1-12-2-3-13(32-17-16-27-15(20(21,22)23)11-28(16)8-7-24-17)10-29(12)18(31)14-4-9-33-19(14)30-25-5-6-26-30/h4-9,11-13H,2-3,10H2,1H3/t12-,13-/m1/s1 ICVMFJDQXAKJHI-CHWSQXEVSA-N 426404 (2-(2H-1,2,3-triazol-2- yl)thiophen-3-yl) ((2R,5R)-2- methyl-5-((2- (trifluoromethyl) imidazo[1,2-alpha]pyrazin- 8-yl)amino)piperidin- 1-yl)methanone::US10526336, Example 23 Orexin receptor type 2 Homo sapiens 99.3 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426404&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732922 434320742 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859814 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2cc(nc12)C(F)(F)F InChI=1S/C20H18F3N7O2S/c1-12-2-3-13(32-17-16-27-15(20(21,22)23)11-28(16)8-7-24-17)10-29(12)18(31)14-4-9-33-19(14)30-25-5-6-26-30/h4-9,11-13H,2-3,10H2,1H3/t12-,13-/m1/s1 ICVMFJDQXAKJHI-CHWSQXEVSA-N 426404 (2-(2H-1,2,3-triazol-2- yl)thiophen-3-yl) ((2R,5R)-2- methyl-5-((2- (trifluoromethyl) imidazo[1,2-alpha]pyrazin- 8-yl)amino)piperidin- 1-yl)methanone::US10526336, Example 23 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426404&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732922 434320742 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859815 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(nc12)C#N InChI=1S/C22H20N8O2/c1-15-6-7-17(32-21-20-27-16(12-23)13-28(20)11-10-24-21)14-29(15)22(31)18-4-2-3-5-19(18)30-25-8-9-26-30/h2-5,8-11,13,15,17H,6-7,14H2,1H3/t15-,17-/m1/s1 RLQHPNKBRKRVBY-NVXWUHKLSA-N 426405 8-(((3R,6R)-1-(2-(2H-1,2,3-triazol-2-yl)benzoyl)-6-methylpiperidin-3-yl)oxy)imidazo[1,2-a]pyrazine-2-carbonitrile::US10526336, Example 24 Orexin receptor type 2 Homo sapiens 88.2 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426405&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439351 434320743 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859816 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(nc12)C#N InChI=1S/C22H20N8O2/c1-15-6-7-17(32-21-20-27-16(12-23)13-28(20)11-10-24-21)14-29(15)22(31)18-4-2-3-5-19(18)30-25-8-9-26-30/h2-5,8-11,13,15,17H,6-7,14H2,1H3/t15-,17-/m1/s1 RLQHPNKBRKRVBY-NVXWUHKLSA-N 426405 8-(((3R,6R)-1-(2-(2H-1,2,3-triazol-2-yl)benzoyl)-6-methylpiperidin-3-yl)oxy)imidazo[1,2-a]pyrazine-2-carbonitrile::US10526336, Example 24 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426405&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439351 434320743 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859817 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(CO)nc12 InChI=1S/C22H23N7O3/c1-15-6-7-17(32-21-20-26-16(14-30)12-27(20)11-10-23-21)13-28(15)22(31)18-4-2-3-5-19(18)29-24-8-9-25-29/h2-5,8-12,15,17,30H,6-7,13-14H2,1H3/t15-,17-/m1/s1 LMWVTTABXGQJTF-NVXWUHKLSA-N 426406 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((2-(hydroxymethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 25 Orexin receptor type 2 Homo sapiens 49.3 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426406&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439368 434320744 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859818 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cc(CO)nc12 InChI=1S/C22H23N7O3/c1-15-6-7-17(32-21-20-26-16(14-30)12-27(20)11-10-23-21)13-28(15)22(31)18-4-2-3-5-19(18)29-24-8-9-25-29/h2-5,8-12,15,17,30H,6-7,13-14H2,1H3/t15-,17-/m1/s1 LMWVTTABXGQJTF-NVXWUHKLSA-N 426406 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((2-(hydroxymethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 25 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426406&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439368 434320744 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859819 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Cl)cnc12 InChI=1S/C21H20ClN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 VBEOVUYQUUYKGO-HUUCEWRRSA-N 426407 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-chloroimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 26::US10526336, Example 27 Orexin receptor type 2 Homo sapiens 12.1 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426407&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439358 434320745 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859820 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Cl)cnc12 InChI=1S/C21H20ClN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 VBEOVUYQUUYKGO-HUUCEWRRSA-N 426407 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-chloroimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 26::US10526336, Example 27 Orexin/Hypocretin receptor type 1 Homo sapiens 1025 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426407&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439358 434320745 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859821 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Cl)cnc12 InChI=1S/C21H20ClN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 VBEOVUYQUUYKGO-HUUCEWRRSA-N 426407 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-chloroimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 26::US10526336, Example 27 Orexin receptor type 2 Homo sapiens 9.10 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426407&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439358 434320745 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859822 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Cl)cnc12 InChI=1S/C21H20ClN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 VBEOVUYQUUYKGO-HUUCEWRRSA-N 426407 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-chloroimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 26::US10526336, Example 27 Orexin/Hypocretin receptor type 1 Homo sapiens 2457 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426407&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439358 434320745 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859823 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1nccn2c(Cl)cnc12 InChI=1S/C23H22ClN5O2/c1-15-6-7-16(31-21-20-27-12-19(24)28(20)11-10-26-21)13-29(15)22(30)17-4-2-3-5-18(17)23(14-25)8-9-23/h2-5,10-12,15-16H,6-9,13H2,1H3/t15-,16-/m1/s1 CAQCOQFDIXDAKI-HZPDHXFCSA-N 426409 1-(2-((2R,5R)-5-((3- chloroimidazo[1,2-alpha] pyrazin-8-yl)oxy)-2- methylpiperidine- 1-carbonyl)phenyl) cyclopropanecarbonitrile::US10526336, Example 28 Orexin receptor type 2 Homo sapiens 9.50 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426409&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439343 434320746 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859824 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1nccn2c(Cl)cnc12 InChI=1S/C23H22ClN5O2/c1-15-6-7-16(31-21-20-27-12-19(24)28(20)11-10-26-21)13-29(15)22(30)17-4-2-3-5-18(17)23(14-25)8-9-23/h2-5,10-12,15-16H,6-9,13H2,1H3/t15-,16-/m1/s1 CAQCOQFDIXDAKI-HZPDHXFCSA-N 426409 1-(2-((2R,5R)-5-((3- chloroimidazo[1,2-alpha] pyrazin-8-yl)oxy)-2- methylpiperidine- 1-carbonyl)phenyl) cyclopropanecarbonitrile::US10526336, Example 28 Orexin/Hypocretin receptor type 1 Homo sapiens 1548 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426409&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439343 434320746 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859825 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2c(Cl)cnc12 InChI=1S/C19H18ClN7O2S/c1-12-2-3-13(29-17-16-22-10-15(20)25(16)8-7-21-17)11-26(12)18(28)14-4-9-30-19(14)27-23-5-6-24-27/h4-10,12-13H,2-3,11H2,1H3/t12-,13-/m1/s1 KGTBEKFEEFNSRO-CHWSQXEVSA-N 426410 (2-(2H-1,2,3-triazol-2- yl)thiophen-3-yl)((2R,5R)- 5-((3-chloroimidazo[1,2-alpha] pyrazin-8-yl)oxy)-2- methylpiperidin-1-yl)methanone::US10526336, Example 29 Orexin receptor type 2 Homo sapiens 14.3 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426410&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439877 434320747 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859826 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2c(Cl)cnc12 InChI=1S/C19H18ClN7O2S/c1-12-2-3-13(29-17-16-22-10-15(20)25(16)8-7-21-17)11-26(12)18(28)14-4-9-30-19(14)27-23-5-6-24-27/h4-10,12-13H,2-3,11H2,1H3/t12-,13-/m1/s1 KGTBEKFEEFNSRO-CHWSQXEVSA-N 426410 (2-(2H-1,2,3-triazol-2- yl)thiophen-3-yl)((2R,5R)- 5-((3-chloroimidazo[1,2-alpha] pyrazin-8-yl)oxy)-2- methylpiperidin-1-yl)methanone::US10526336, Example 29 Orexin/Hypocretin receptor type 1 Homo sapiens 2555 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426410&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439877 434320747 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859827 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccn2c(Cl)cnc12 InChI=1S/C21H21ClN8O/c1-14-6-7-15(27-19-20-24-12-18(22)28(20)11-10-23-19)13-29(14)21(31)16-4-2-3-5-17(16)30-25-8-9-26-30/h2-5,8-12,14-15H,6-7,13H2,1H3,(H,23,27)/t14-,15-/m1/s1 FQNVUUZOFSAQLW-HUUCEWRRSA-N 426411 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-chloroimidazo[1,2-a]pyrazin-8-yl)amino)-2-methylpiperidin-1-yl)methanone::US10526336, Example 30 Orexin receptor type 2 Homo sapiens 13.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426411&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439378 434320748 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859828 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccn2c(Cl)cnc12 InChI=1S/C21H21ClN8O/c1-14-6-7-15(27-19-20-24-12-18(22)28(20)11-10-23-19)13-29(14)21(31)16-4-2-3-5-17(16)30-25-8-9-26-30/h2-5,8-12,14-15H,6-7,13H2,1H3,(H,23,27)/t14-,15-/m1/s1 FQNVUUZOFSAQLW-HUUCEWRRSA-N 426411 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-chloroimidazo[1,2-a]pyrazin-8-yl)amino)-2-methylpiperidin-1-yl)methanone::US10526336, Example 30 Orexin/Hypocretin receptor type 1 Homo sapiens 916 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426411&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439378 434320748 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859829 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Nc1nccn2c(Cl)cnc12 InChI=1S/C23H22ClN7O/c1-15-7-8-16(29-21-22-28-13-19(24)30(22)12-11-27-21)14-31(15)23(32)18-6-3-2-5-17(18)20-25-9-4-10-26-20/h2-6,9-13,15-16H,7-8,14H2,1H3,(H,27,29)/t15-,16-/m1/s1 GAGRISKVZAYARB-HZPDHXFCSA-N 426412 ((2R,5R)-5-((3-chloroimidazo[1,2-a]pyrazin-8-yl)amino)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US10526336, Example 31 Orexin receptor type 2 Homo sapiens 23.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426412&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439331 434320749 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859830 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Nc1nccn2c(Cl)cnc12 InChI=1S/C23H22ClN7O/c1-15-7-8-16(29-21-22-28-13-19(24)30(22)12-11-27-21)14-31(15)23(32)18-6-3-2-5-17(18)20-25-9-4-10-26-20/h2-6,9-13,15-16H,7-8,14H2,1H3,(H,27,29)/t15-,16-/m1/s1 GAGRISKVZAYARB-HZPDHXFCSA-N 426412 ((2R,5R)-5-((3-chloroimidazo[1,2-a]pyrazin-8-yl)amino)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US10526336, Example 31 Orexin/Hypocretin receptor type 1 Homo sapiens 1487 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426412&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439331 434320749 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859831 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(F)cnc12 InChI=1S/C21H20FN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 FKIJOIAFJRXYNY-HUUCEWRRSA-N 426413 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-fluoroimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 32 Orexin receptor type 2 Homo sapiens 12.6 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426413&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439361 434320750 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859832 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(F)cnc12 InChI=1S/C21H20FN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 FKIJOIAFJRXYNY-HUUCEWRRSA-N 426413 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-fluoroimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 32 Orexin/Hypocretin receptor type 1 Homo sapiens 1173 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426413&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439361 434320750 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859833 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Br)cnc12 InChI=1S/C21H20BrN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 HXEUUKAITDSZMK-HUUCEWRRSA-N 426414 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-bromoimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 33::US10526336, Example 41::US10526336, Example 57 Orexin receptor type 2 Homo sapiens 8.90 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426414&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439356 434320751 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859834 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Br)cnc12 InChI=1S/C21H20BrN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 HXEUUKAITDSZMK-HUUCEWRRSA-N 426414 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-bromoimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 33::US10526336, Example 41::US10526336, Example 57 Orexin/Hypocretin receptor type 1 Homo sapiens 1201 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426414&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439356 434320751 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859835 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(C)cnc12 InChI=1S/C22H23N7O2/c1-15-7-8-17(31-21-20-24-13-16(2)27(20)12-11-23-21)14-28(15)22(30)18-5-3-4-6-19(18)29-25-9-10-26-29/h3-6,9-13,15,17H,7-8,14H2,1-2H3/t15-,17-/m1/s1 QJMOCERTMUIMSD-NVXWUHKLSA-N 426415 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 34 Orexin receptor type 2 Homo sapiens 16.3 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426415&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439381 434320752 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859836 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(C)cnc12 InChI=1S/C22H23N7O2/c1-15-7-8-17(31-21-20-24-13-16(2)27(20)12-11-23-21)14-28(15)22(30)18-5-3-4-6-19(18)29-25-9-10-26-29/h3-6,9-13,15,17H,7-8,14H2,1-2H3/t15-,17-/m1/s1 QJMOCERTMUIMSD-NVXWUHKLSA-N 426415 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 34 Orexin/Hypocretin receptor type 1 Homo sapiens 9061 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426415&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439381 434320752 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859837 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(cnc12)C#N InChI=1S/C22H20N8O2/c1-15-6-7-17(32-21-20-25-13-16(12-23)28(20)11-10-24-21)14-29(15)22(31)18-4-2-3-5-19(18)30-26-8-9-27-30/h2-5,8-11,13,15,17H,6-7,14H2,1H3/t15-,17-/m1/s1 DQDCQMQOQADHKB-NVXWUHKLSA-N 426416 8-(((3R,6R)-1-(2-(2H-1,2,3-triazol-2-yl)benzoyl)-6-methylpiperidin-3-yl)oxy)imidazo[1,2-a]pyrazine-3-carbonitrile::US10526336, Example 35 Orexin receptor type 2 Homo sapiens 73.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426416&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439341 434320753 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859838 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(cnc12)C#N InChI=1S/C22H20N8O2/c1-15-6-7-17(32-21-20-25-13-16(12-23)28(20)11-10-24-21)14-29(15)22(31)18-4-2-3-5-19(18)30-26-8-9-27-30/h2-5,8-11,13,15,17H,6-7,14H2,1H3/t15-,17-/m1/s1 DQDCQMQOQADHKB-NVXWUHKLSA-N 426416 8-(((3R,6R)-1-(2-(2H-1,2,3-triazol-2-yl)benzoyl)-6-methylpiperidin-3-yl)oxy)imidazo[1,2-a]pyrazine-3-carbonitrile::US10526336, Example 35 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426416&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439341 434320753 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859839 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(C=C)cnc12 InChI=1S/C23H23N7O2/c1-3-17-14-25-21-22(24-12-13-28(17)21)32-18-9-8-16(2)29(15-18)23(31)19-6-4-5-7-20(19)30-26-10-11-27-30/h3-7,10-14,16,18H,1,8-9,15H2,2H3/t16-,18-/m1/s1 QTNXJGLHZAQRQH-SJLPKXTDSA-N 426417 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-vinylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 36 Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426417&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439376 434320754 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859840 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(C=C)cnc12 InChI=1S/C23H23N7O2/c1-3-17-14-25-21-22(24-12-13-28(17)21)32-18-9-8-16(2)29(15-18)23(31)19-6-4-5-7-20(19)30-26-10-11-27-30/h3-7,10-14,16,18H,1,8-9,15H2,2H3/t16-,18-/m1/s1 QTNXJGLHZAQRQH-SJLPKXTDSA-N 426417 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-vinylimidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 36 Orexin/Hypocretin receptor type 1 Homo sapiens 5100 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426417&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439376 434320754 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859841 CCc1cnc2c(O[C@@H]3CC[C@@H](C)N(C3)C(=O)c3ccccc3-n3nccn3)nccn12 InChI=1S/C23H25N7O2/c1-3-17-14-25-21-22(24-12-13-28(17)21)32-18-9-8-16(2)29(15-18)23(31)19-6-4-5-7-20(19)30-26-10-11-27-30/h4-7,10-14,16,18H,3,8-9,15H2,1-2H3/t16-,18-/m1/s1 GFOVCMDAPSXOEU-SJLPKXTDSA-N 426418 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-ethylimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 37 Orexin receptor type 2 Homo sapiens 29.2 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426418&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439347 434320755 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859842 CCc1cnc2c(O[C@@H]3CC[C@@H](C)N(C3)C(=O)c3ccccc3-n3nccn3)nccn12 InChI=1S/C23H25N7O2/c1-3-17-14-25-21-22(24-12-13-28(17)21)32-18-9-8-16(2)29(15-18)23(31)19-6-4-5-7-20(19)30-26-10-11-27-30/h4-7,10-14,16,18H,3,8-9,15H2,1-2H3/t16-,18-/m1/s1 GFOVCMDAPSXOEU-SJLPKXTDSA-N 426418 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-ethylimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 37 Orexin/Hypocretin receptor type 1 Homo sapiens 1774 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426418&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439347 434320755 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859843 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H21F2N7O2/c1-14-6-7-15(33-21-20-26-12-18(19(23)24)29(20)11-10-25-21)13-30(14)22(32)16-4-2-3-5-17(16)31-27-8-9-28-31/h2-5,8-12,14-15,19H,6-7,13H2,1H3/t14-,15-/m1/s1 QWMDVLUNTCAPNA-HUUCEWRRSA-N 426419 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-(difluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 38 Orexin receptor type 2 Homo sapiens 17.6 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426419&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439350 434320756 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859844 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H21F2N7O2/c1-14-6-7-15(33-21-20-26-12-18(19(23)24)29(20)11-10-25-21)13-30(14)22(32)16-4-2-3-5-17(16)31-27-8-9-28-31/h2-5,8-12,14-15,19H,6-7,13H2,1H3/t14-,15-/m1/s1 QWMDVLUNTCAPNA-HUUCEWRRSA-N 426419 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-(difluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 38 Orexin/Hypocretin receptor type 1 Homo sapiens 1791 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426419&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439350 434320756 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859845 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2c(CF)cnc12 InChI=1S/C22H25FN4O4S/c1-15-7-8-18(31-21-20-25-12-17(11-23)26(20)10-9-24-21)13-27(15)22(28)19-6-4-3-5-16(19)14-32(2,29)30/h3-6,9-10,12,15,18H,7-8,11,13-14H2,1-2H3/t15-,18-/m1/s1 PFARSPDONWGHJD-CRAIPNDOSA-N 426420 ((2R,5R)-5-((3-(difluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)(2-((methylsulfonyl)methyl)phenyl)methanone::US10526336, Example 39 Orexin receptor type 2 Homo sapiens 62.6 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426420&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732923 434320757 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859846 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2c(CF)cnc12 InChI=1S/C22H25FN4O4S/c1-15-7-8-18(31-21-20-25-12-17(11-23)26(20)10-9-24-21)13-27(15)22(28)19-6-4-3-5-16(19)14-32(2,29)30/h3-6,9-10,12,15,18H,7-8,11,13-14H2,1-2H3/t15-,18-/m1/s1 PFARSPDONWGHJD-CRAIPNDOSA-N 426420 ((2R,5R)-5-((3-(difluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)(2-((methylsulfonyl)methyl)phenyl)methanone::US10526336, Example 39 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426420&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732923 434320757 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859847 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C20H19F2N7O2S/c1-12-2-3-13(31-18-17-24-10-15(16(21)22)27(17)8-7-23-18)11-28(12)19(30)14-4-9-32-20(14)29-25-5-6-26-29/h4-10,12-13,16H,2-3,11H2,1H3/t12-,13-/m1/s1 AFDAELLBWXUUIA-CHWSQXEVSA-N 426421 (2-(2H-1,2,3-triazol-2-yl)thiophen-3- yl)((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 40 Orexin receptor type 2 Homo sapiens 10.5 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426421&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439854 434320758 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859848 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C20H19F2N7O2S/c1-12-2-3-13(31-18-17-24-10-15(16(21)22)27(17)8-7-23-18)11-28(12)19(30)14-4-9-32-20(14)29-25-5-6-26-29/h4-10,12-13,16H,2-3,11H2,1H3/t12-,13-/m1/s1 AFDAELLBWXUUIA-CHWSQXEVSA-N 426421 (2-(2H-1,2,3-triazol-2-yl)thiophen-3- yl)((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 40 Orexin/Hypocretin receptor type 1 Homo sapiens 9025 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426421&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439854 434320758 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859849 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Br)cnc12 InChI=1S/C21H20BrN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 HXEUUKAITDSZMK-HUUCEWRRSA-N 426414 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-bromoimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 33::US10526336, Example 41::US10526336, Example 57 Orexin receptor type 2 Homo sapiens 45.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426414&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439356 434320751 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859850 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Br)cnc12 InChI=1S/C21H20BrN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 HXEUUKAITDSZMK-HUUCEWRRSA-N 426414 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-bromoimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 33::US10526336, Example 41::US10526336, Example 57 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426414&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439356 434320751 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859851 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#C)Oc1nccn2c(cnc12)C(F)F InChI=1S/C25H24F2N4O2/c1-3-25(10-11-25)19-7-5-4-6-18(19)24(32)31-15-17(9-8-16(31)2)33-23-22-29-14-20(21(26)27)30(22)13-12-28-23/h1,4-7,12-14,16-17,21H,8-11,15H2,2H3/t16-,17-/m1/s1 VYULUXVFODKIIA-IAGOWNOFSA-N 426423 1-(2-((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidine-1- carbonyl)phenyl)cyclopropanecarbonitrile::US10526336, Example 42 Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426423&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732924 434320759 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859852 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#C)Oc1nccn2c(cnc12)C(F)F InChI=1S/C25H24F2N4O2/c1-3-25(10-11-25)19-7-5-4-6-18(19)24(32)31-15-17(9-8-16(31)2)33-23-22-29-14-20(21(26)27)30(22)13-12-28-23/h1,4-7,12-14,16-17,21H,8-11,15H2,2H3/t16-,17-/m1/s1 VYULUXVFODKIIA-IAGOWNOFSA-N 426423 1-(2-((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidine-1- carbonyl)phenyl)cyclopropanecarbonitrile::US10526336, Example 42 Orexin/Hypocretin receptor type 1 Homo sapiens 1795 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426423&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732924 434320759 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859853 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H20F3N7O2/c1-13-2-4-15(34-21-20-27-11-18(19(24)25)30(20)9-8-26-21)12-31(13)22(33)16-5-3-14(23)10-17(16)32-28-6-7-29-32/h3,5-11,13,15,19H,2,4,12H2,1H3/t13-,15-/m1/s1 IQHJBOGYYVAOMD-UKRRQHHQSA-N 426424 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(4-fluoro- 2-(2H-1,2,3-triazol-2- yl)phenyl)methanone::US10526336, Example 43 Orexin receptor type 2 Homo sapiens 15.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426424&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439798 434320760 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859854 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H20F3N7O2/c1-13-2-4-15(34-21-20-27-11-18(19(24)25)30(20)9-8-26-21)12-31(13)22(33)16-5-3-14(23)10-17(16)32-28-6-7-29-32/h3,5-11,13,15,19H,2,4,12H2,1H3/t13-,15-/m1/s1 IQHJBOGYYVAOMD-UKRRQHHQSA-N 426424 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(4-fluoro- 2-(2H-1,2,3-triazol-2- yl)phenyl)methanone::US10526336, Example 43 Orexin/Hypocretin receptor type 1 Homo sapiens 1419 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426424&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439798 434320760 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859855 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C21H20F2N8O2/c1-13-6-7-14(33-20-19-25-10-17(18(22)23)29(19)9-8-24-20)11-30(13)21(32)15-4-2-3-5-16(15)31-27-12-26-28-31/h2-5,8-10,12-14,18H,6-7,11H2,1H3/t13-,14-/m1/s1 GQGYSGKNILVDGT-ZIAGYGMSSA-N 426425 (2-(2H-tetrazol-2-yl)phenyl)((2R,5R)-5- ((3-(difluoromethyl)imidazo[1,2-alpha] pyrazin-8-yl)oxy)-2-methylpiperidin- 1-yl)methanone::US10526336, Example 44 Orexin receptor type 2 Homo sapiens 9.60 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426425&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439367 434320761 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859856 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C21H20F2N8O2/c1-13-6-7-14(33-20-19-25-10-17(18(22)23)29(19)9-8-24-20)11-30(13)21(32)15-4-2-3-5-16(15)31-27-12-26-28-31/h2-5,8-10,12-14,18H,6-7,11H2,1H3/t13-,14-/m1/s1 GQGYSGKNILVDGT-ZIAGYGMSSA-N 426425 (2-(2H-tetrazol-2-yl)phenyl)((2R,5R)-5- ((3-(difluoromethyl)imidazo[1,2-alpha] pyrazin-8-yl)oxy)-2-methylpiperidin- 1-yl)methanone::US10526336, Example 44 Orexin/Hypocretin receptor type 1 Homo sapiens 2061 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426425&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439367 434320761 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859857 COCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H24F2N4O3/c1-14-7-8-16(12-28(14)22(29)17-6-4-3-5-15(17)13-30-2)31-21-20-26-11-18(19(23)24)27(20)10-9-25-21/h3-6,9-11,14,16,19H,7-8,12-13H2,1-2H3/t14-,16-/m1/s1 XTIYCRKTDSENBP-GDBMZVCRSA-N 426426 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(2- (methoxymethyl)phenyl)methanone::US10526336, Example 45 Orexin receptor type 2 Homo sapiens 108 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426426&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439860 434320762 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859858 COCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H24F2N4O3/c1-14-7-8-16(12-28(14)22(29)17-6-4-3-5-15(17)13-30-2)31-21-20-26-11-18(19(23)24)27(20)10-9-25-21/h3-6,9-11,14,16,19H,7-8,12-13H2,1-2H3/t14-,16-/m1/s1 XTIYCRKTDSENBP-GDBMZVCRSA-N 426426 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(2- (methoxymethyl)phenyl)methanone::US10526336, Example 45 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426426&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439860 434320762 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859859 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-n1cccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C21H20F2N8O2/c1-13-3-4-14(33-20-19-27-11-15(17(22)23)29(19)10-8-26-20)12-30(13)21(32)16-18(25-7-6-24-16)31-9-2-5-28-31/h2,5-11,13-14,17H,3-4,12H2,1H3/t13-,14-/m1/s1 ZGPDWBJMVNXYPC-ZIAGYGMSSA-N 426427 (3-(1H-pyrazol-1-yl)pyrazin-2- yl)((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin- 8-yl)oxy)-2-methylpiperidin-1- yl)methanone::US10526336, Example 46 Orexin receptor type 2 Homo sapiens 61.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426427&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439372 434320763 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859860 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-n1cccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C21H20F2N8O2/c1-13-3-4-14(33-20-19-27-11-15(17(22)23)29(19)10-8-26-20)12-30(13)21(32)16-18(25-7-6-24-16)31-9-2-5-28-31/h2,5-11,13-14,17H,3-4,12H2,1H3/t13-,14-/m1/s1 ZGPDWBJMVNXYPC-ZIAGYGMSSA-N 426427 (3-(1H-pyrazol-1-yl)pyrazin-2- yl)((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin- 8-yl)oxy)-2-methylpiperidin-1- yl)methanone::US10526336, Example 46 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426427&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439372 434320763 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859861 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-c1ccccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C23H21F2N7O2/c1-14-5-6-15(34-22-21-30-12-17(20(24)25)31(21)11-10-29-22)13-32(14)23(33)19-18(27-8-9-28-19)16-4-2-3-7-26-16/h2-4,7-12,14-15,20H,5-6,13H2,1H3/t14-,15-/m1/s1 ZSWRDPFZUGFWSY-HUUCEWRRSA-N 426428 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(3- (pyridin-2-yl)pyrazin-2-yl)methanone::US10526336, Example 47 Orexin receptor type 2 Homo sapiens 64.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426428&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439848 434320764 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859862 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-c1ccccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C23H21F2N7O2/c1-14-5-6-15(34-22-21-30-12-17(20(24)25)31(21)11-10-29-22)13-32(14)23(33)19-18(27-8-9-28-19)16-4-2-3-7-26-16/h2-4,7-12,14-15,20H,5-6,13H2,1H3/t14-,15-/m1/s1 ZSWRDPFZUGFWSY-HUUCEWRRSA-N 426428 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(3- (pyridin-2-yl)pyrazin-2-yl)methanone::US10526336, Example 47 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426428&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439848 434320764 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859863 COC(=O)c1nccnc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2c(cnc12)C(F)F InChI=1S/C20H20F2N6O4/c1-11-3-4-12(32-18-17-26-9-13(16(21)22)27(17)8-7-25-18)10-28(11)19(29)14-15(20(30)31-2)24-6-5-23-14/h5-9,11-12,16H,3-4,10H2,1-2H3/t11-,12-/m1/s1 ADMNEWANDIGMEI-VXGBXAGGSA-N 426429 US10526336, Example 48::methyl 2-((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidine-1- carbonyl)benzoate Orexin receptor type 2 Homo sapiens 24.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426429&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732925 434320765 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859864 COC(=O)c1nccnc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2c(cnc12)C(F)F InChI=1S/C20H20F2N6O4/c1-11-3-4-12(32-18-17-26-9-13(16(21)22)27(17)8-7-25-18)10-28(11)19(29)14-15(20(30)31-2)24-6-5-23-14/h5-9,11-12,16H,3-4,10H2,1-2H3/t11-,12-/m1/s1 ADMNEWANDIGMEI-VXGBXAGGSA-N 426429 US10526336, Example 48::methyl 2-((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidine-1- carbonyl)benzoate Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426429&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732925 434320765 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859865 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-c1ccccc1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C25H23F2N5O2/c1-16-9-10-18(34-24-23-30-14-20(22(26)27)31(23)13-12-29-24)15-32(16)25(33)21-19(8-5-11-28-21)17-6-3-2-4-7-17/h2-8,11-14,16,18,22H,9-10,15H2,1H3/t16-,18-/m1/s1 LLYBAHJFQWHZRJ-SJLPKXTDSA-N 426430 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(3- phenylpyridin-2-yl)methanone::US10526336, Example 49 Orexin receptor type 2 Homo sapiens 51.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426430&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439884 434320766 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859866 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-c1ccccc1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C25H23F2N5O2/c1-16-9-10-18(34-24-23-30-14-20(22(26)27)31(23)13-12-29-24)15-32(16)25(33)21-19(8-5-11-28-21)17-6-3-2-4-7-17/h2-8,11-14,16,18,22H,9-10,15H2,1H3/t16-,18-/m1/s1 LLYBAHJFQWHZRJ-SJLPKXTDSA-N 426430 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(3- phenylpyridin-2-yl)methanone::US10526336, Example 49 Orexin/Hypocretin receptor type 1 Homo sapiens 2701 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426430&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439884 434320766 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859867 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1NCC(F)(F)F)Oc1nccn2c(cnc12)C(F)F InChI=1S/C21H21F5N6O2/c1-12-4-5-13(34-19-18-29-9-15(16(22)23)31(18)8-7-28-19)10-32(12)20(33)14-3-2-6-27-17(14)30-11-21(24,25)26/h2-3,6-9,12-13,16H,4-5,10-11H2,1H3,(H,27,30)/t12-,13-/m1/s1 YIPVYUSDYSQSIL-CHWSQXEVSA-N 426431 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(2-(2,2,2- trifluoroethoxy)pyridin-3-yl)methanone::US10526336, Example 50 Orexin receptor type 2 Homo sapiens 26.5 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426431&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732926 434320767 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859868 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1NCC(F)(F)F)Oc1nccn2c(cnc12)C(F)F InChI=1S/C21H21F5N6O2/c1-12-4-5-13(34-19-18-29-9-15(16(22)23)31(18)8-7-28-19)10-32(12)20(33)14-3-2-6-27-17(14)30-11-21(24,25)26/h2-3,6-9,12-13,16H,4-5,10-11H2,1H3,(H,27,30)/t12-,13-/m1/s1 YIPVYUSDYSQSIL-CHWSQXEVSA-N 426431 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(2-(2,2,2- trifluoroethoxy)pyridin-3-yl)methanone::US10526336, Example 50 Orexin/Hypocretin receptor type 1 Homo sapiens 2132 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426431&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732926 434320767 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859869 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)F)Oc1nccn2c(cnc12)C(F)F InChI=1S/C21H21F4N5O3/c1-12-4-5-13(33-20-18-28-9-15(17(24)25)29(18)8-7-27-20)10-30(12)21(31)14-3-2-6-26-19(14)32-11-16(22)23/h2-3,6-9,12-13,16-17H,4-5,10-11H2,1H3/t12-,13-/m1/s1 JAIIJXWGZMDYNZ-CHWSQXEVSA-N 426432 (2-(2,2-difluoroethoxy)pyridin-3- yl)((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin- 8-yl)oxy)-2-methylpiperidin-1-yl) methanone::US10526336, Example 51 Orexin receptor type 2 Homo sapiens 31.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426432&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439862 434320768 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859870 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)F)Oc1nccn2c(cnc12)C(F)F InChI=1S/C21H21F4N5O3/c1-12-4-5-13(33-20-18-28-9-15(17(24)25)29(18)8-7-27-20)10-30(12)21(31)14-3-2-6-26-19(14)32-11-16(22)23/h2-3,6-9,12-13,16-17H,4-5,10-11H2,1H3/t12-,13-/m1/s1 JAIIJXWGZMDYNZ-CHWSQXEVSA-N 426432 (2-(2,2-difluoroethoxy)pyridin-3- yl)((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin- 8-yl)oxy)-2-methylpiperidin-1-yl) methanone::US10526336, Example 51 Orexin/Hypocretin receptor type 1 Homo sapiens 8015 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426432&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439862 434320768 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859871 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-n1cccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H21F2N7O2/c1-14-5-6-15(33-21-20-27-12-17(18(23)24)29(20)11-9-26-21)13-30(14)22(32)16-4-2-7-25-19(16)31-10-3-8-28-31/h2-4,7-12,14-15,18H,5-6,13H2,1H3/t14-,15-/m1/s1 ABZHMQSVRFLUKD-HUUCEWRRSA-N 426433 (2-(1H-pyrazol-1-yl)pyridin-3- yl)((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 52 Orexin receptor type 2 Homo sapiens 15.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426433&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439329 434320769 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859872 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-n1cccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H21F2N7O2/c1-14-5-6-15(33-21-20-27-12-17(18(23)24)29(20)11-9-26-21)13-30(14)22(32)16-4-2-7-25-19(16)31-10-3-8-28-31/h2-4,7-12,14-15,18H,5-6,13H2,1H3/t14-,15-/m1/s1 ABZHMQSVRFLUKD-HUUCEWRRSA-N 426433 (2-(1H-pyrazol-1-yl)pyridin-3- yl)((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 52 Orexin/Hypocretin receptor type 1 Homo sapiens 1570 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426433&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439329 434320769 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859873 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1cnccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C24H22F2N6O2/c1-15-6-7-16(34-23-22-30-13-20(21(25)26)31(22)11-10-29-23)14-32(15)24(33)18-5-3-2-4-17(18)19-12-27-8-9-28-19/h2-5,8-13,15-16,21H,6-7,14H2,1H3/t15-,16-/m1/s1 XVSJSOYELCBCEQ-HZPDHXFCSA-N 426434 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(2- (pyrazin-2-yl)phenyl)methanone::US10526336, Example 53 Orexin receptor type 2 Homo sapiens 21.3 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426434&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439785 434320770 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859874 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1cnccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C24H22F2N6O2/c1-15-6-7-16(34-23-22-30-13-20(21(25)26)31(22)11-10-29-23)14-32(15)24(33)18-5-3-2-4-17(18)19-12-27-8-9-28-19/h2-5,8-13,15-16,21H,6-7,14H2,1H3/t15-,16-/m1/s1 XVSJSOYELCBCEQ-HZPDHXFCSA-N 426434 ((2R,5R)-5-((3- (difluoromethyl)imidazo[1,2-alpha]pyrazin-8- yl)oxy)-2-methylpiperidin-1-yl)(2- (pyrazin-2-yl)phenyl)methanone::US10526336, Example 53 Orexin/Hypocretin receptor type 1 Homo sapiens 2126 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426434&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439785 434320770 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859875 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C24H22F2N6O2/c1-15-7-8-16(34-23-22-30-13-19(20(25)26)31(22)12-11-29-23)14-32(15)24(33)18-6-3-2-5-17(18)21-27-9-4-10-28-21/h2-6,9-13,15-16,20H,7-8,14H2,1H3/t15-,16-/m1/s1 ZQZHNLCVEUFXGD-HZPDHXFCSA-N 426435 ((2R,5R)-5-((3-(difluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US10526336, Example 54 Orexin receptor type 2 Homo sapiens 24.1 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426435&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439332 434320771 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859876 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C24H22F2N6O2/c1-15-7-8-16(34-23-22-30-13-19(20(25)26)31(22)12-11-29-23)14-32(15)24(33)18-6-3-2-5-17(18)21-27-9-4-10-28-21/h2-6,9-13,15-16,20H,7-8,14H2,1H3/t15-,16-/m1/s1 ZQZHNLCVEUFXGD-HZPDHXFCSA-N 426435 ((2R,5R)-5-((3-(difluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US10526336, Example 54 Orexin/Hypocretin receptor type 1 Homo sapiens 1443 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426435&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439332 434320771 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859877 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H20F2N6O2S/c1-13-3-4-14(32-21-20-28-9-17(18(23)24)29(20)8-7-27-21)10-30(13)22(31)16-12-33-11-15(16)19-25-5-2-6-26-19/h2,5-9,11-14,18H,3-4,10H2,1H3/t13-,14-/m1/s1 DAHVBRXERQXKAM-ZIAGYGMSSA-N 426436 ((2R,5R)-5-((3- (difluoromethyl)imidazo [1,2-alpha]pyrazin- 8-yl)oxy)-2- methylpiperidin-1-yl)(4- (pyrimidin-2-yl)thiophen- 3-yl)methanone::US10526336, Example 55 Orexin receptor type 2 Homo sapiens 44.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426436&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439878 434320772 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859878 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H20F2N6O2S/c1-13-3-4-14(32-21-20-28-9-17(18(23)24)29(20)8-7-27-21)10-30(13)22(31)16-12-33-11-15(16)19-25-5-2-6-26-19/h2,5-9,11-14,18H,3-4,10H2,1H3/t13-,14-/m1/s1 DAHVBRXERQXKAM-ZIAGYGMSSA-N 426436 ((2R,5R)-5-((3- (difluoromethyl)imidazo [1,2-alpha]pyrazin- 8-yl)oxy)-2- methylpiperidin-1-yl)(4- (pyrimidin-2-yl)thiophen- 3-yl)methanone::US10526336, Example 55 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426436&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439878 434320772 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859879 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H20F2N6O2S/c1-13-3-4-14(32-21-20-28-11-16(18(23)24)29(20)9-8-27-21)12-30(13)22(31)15-5-10-33-17(15)19-25-6-2-7-26-19/h2,5-11,13-14,18H,3-4,12H2,1H3/t13-,14-/m1/s1 PGBGXXUVCLEVCA-ZIAGYGMSSA-N 426437 ((2R,5R)-5-((3 (difluoromethyl)imidazo [1,2-alpha]pyrazin- 8-yl)oxy)-2- methylpiperidin-1-yl)(2- (pyrimidin-2-yl)thiophen- 3-yl)methanone::US10526336, Example 56 Orexin receptor type 2 Homo sapiens 53.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426437&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439809 434320773 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859880 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1nccn2c(cnc12)C(F)F InChI=1S/C22H20F2N6O2S/c1-13-3-4-14(32-21-20-28-11-16(18(23)24)29(20)9-8-27-21)12-30(13)22(31)15-5-10-33-17(15)19-25-6-2-7-26-19/h2,5-11,13-14,18H,3-4,12H2,1H3/t13-,14-/m1/s1 PGBGXXUVCLEVCA-ZIAGYGMSSA-N 426437 ((2R,5R)-5-((3 (difluoromethyl)imidazo [1,2-alpha]pyrazin- 8-yl)oxy)-2- methylpiperidin-1-yl)(2- (pyrimidin-2-yl)thiophen- 3-yl)methanone::US10526336, Example 56 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426437&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439809 434320773 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859881 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Br)cnc12 InChI=1S/C21H20BrN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 HXEUUKAITDSZMK-HUUCEWRRSA-N 426414 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-bromoimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 33::US10526336, Example 41::US10526336, Example 57 Orexin receptor type 2 Homo sapiens 13.1 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426414&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439356 434320751 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859882 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(Br)cnc12 InChI=1S/C21H20BrN7O2/c1-14-6-7-15(31-20-19-24-12-18(22)27(19)11-10-23-20)13-28(14)21(30)16-4-2-3-5-17(16)29-25-8-9-26-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 HXEUUKAITDSZMK-HUUCEWRRSA-N 426414 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-bromoimidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 33::US10526336, Example 41::US10526336, Example 57 Orexin/Hypocretin receptor type 1 Homo sapiens 1505 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426414&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439356 434320751 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859883 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C20H18F3N7O2S/c1-12-2-3-13(32-17-16-25-10-15(20(21,22)23)28(16)8-7-24-17)11-29(12)18(31)14-4-9-33-19(14)30-26-5-6-27-30/h4-10,12-13H,2-3,11H2,1H3/t12-,13-/m1/s1 YXSCINZYKDOOTA-CHWSQXEVSA-N 426439 (2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl)((2R,5R)-2-methyl-5-((3-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 58 Orexin receptor type 2 Homo sapiens 20.4 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426439&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439337 434320774 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859884 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C20H18F3N7O2S/c1-12-2-3-13(32-17-16-25-10-15(20(21,22)23)28(16)8-7-24-17)11-29(12)18(31)14-4-9-33-19(14)30-26-5-6-27-30/h4-10,12-13H,2-3,11H2,1H3/t12-,13-/m1/s1 YXSCINZYKDOOTA-CHWSQXEVSA-N 426439 (2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl)((2R,5R)-2-methyl-5-((3-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 58 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426439&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439337 434320774 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859885 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C24H22F3N5O2/c1-15-6-7-16(34-21-20-30-12-19(24(25,26)27)31(20)11-10-29-21)13-32(15)22(33)17-4-2-3-5-18(17)23(14-28)8-9-23/h2-5,10-12,15-16H,6-9,13H2,1H3/t15-,16-/m1/s1 XGNBFZFFJLSWRR-HZPDHXFCSA-N 426440 1-(2-((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8-yl)oxy) piperidine-1- carbonyl)phenyl) cyclopropanecarbonitrile::US10526336, Example 59 Orexin receptor type 2 Homo sapiens 12.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426440&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439880 434320775 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859886 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C24H22F3N5O2/c1-15-6-7-16(34-21-20-30-12-19(24(25,26)27)31(20)11-10-29-21)13-32(15)22(33)17-4-2-3-5-18(17)23(14-28)8-9-23/h2-5,10-12,15-16H,6-9,13H2,1H3/t15-,16-/m1/s1 XGNBFZFFJLSWRR-HZPDHXFCSA-N 426440 1-(2-((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8-yl)oxy) piperidine-1- carbonyl)phenyl) cyclopropanecarbonitrile::US10526336, Example 59 Orexin/Hypocretin receptor type 1 Homo sapiens 4383 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426440&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439880 434320775 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859887 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C21H19F3N8O2/c1-13-6-7-14(34-19-18-26-10-17(21(22,23)24)30(18)9-8-25-19)11-31(13)20(33)15-4-2-3-5-16(15)32-28-12-27-29-32/h2-5,8-10,12-14H,6-7,11H2,1H3/t13-,14-/m1/s1 MTTWBUAOCWCXGN-ZIAGYGMSSA-N 426441 (2-(2H-tetrazol-2- yl)phenyl)((2R,5R)-2- methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1- yl)methanone::US10526336, Example 60 Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426441&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439853 434320776 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859888 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C21H19F3N8O2/c1-13-6-7-14(34-19-18-26-10-17(21(22,23)24)30(18)9-8-25-19)11-31(13)20(33)15-4-2-3-5-16(15)32-28-12-27-29-32/h2-5,8-10,12-14H,6-7,11H2,1H3/t13-,14-/m1/s1 MTTWBUAOCWCXGN-ZIAGYGMSSA-N 426441 (2-(2H-tetrazol-2- yl)phenyl)((2R,5R)-2- methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1- yl)methanone::US10526336, Example 60 Orexin/Hypocretin receptor type 1 Homo sapiens 8623 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426441&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439853 434320776 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859889 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C22H23F3N4O4S/c1-14-7-8-16(33-20-19-27-11-18(22(23,24)25)28(19)10-9-26-20)12-29(14)21(30)17-6-4-3-5-15(17)13-34(2,31)32/h3-6,9-11,14,16H,7-8,12-13H2,1-2H3/t14-,16-/m1/s1 NDWUNKKITCRFDY-GDBMZVCRSA-N 426442 ((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)(2- ((methylsulfonyl)methyl) phenyl)methanone::US10526336, Example 61 Orexin receptor type 2 Homo sapiens 170 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426442&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439786 434320777 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859890 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C22H23F3N4O4S/c1-14-7-8-16(33-20-19-27-11-18(22(23,24)25)28(19)10-9-26-20)12-29(14)21(30)17-6-4-3-5-15(17)13-34(2,31)32/h3-6,9-11,14,16H,7-8,12-13H2,1-2H3/t14-,16-/m1/s1 NDWUNKKITCRFDY-GDBMZVCRSA-N 426442 ((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)(2- ((methylsulfonyl)methyl) phenyl)methanone::US10526336, Example 61 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426442&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439786 434320777 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859891 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-c1ccccc1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C25H22F3N5O2/c1-16-9-10-18(35-23-22-31-14-20(25(26,27)28)32(22)13-12-30-23)15-33(16)24(34)21-19(8-5-11-29-21)17-6-3-2-4-7-17/h2-8,11-14,16,18H,9-10,15H2,1H3/t16-,18-/m1/s1 INHBZTGXXOKSJN-SJLPKXTDSA-N 426443 ((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)(3- phenylpyridin-2-yl)methanone::US10526336, Example 62 Orexin receptor type 2 Homo sapiens 46.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426443&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439833 434320778 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859892 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-c1ccccc1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C25H22F3N5O2/c1-16-9-10-18(35-23-22-31-14-20(25(26,27)28)32(22)13-12-30-23)15-33(16)24(34)21-19(8-5-11-29-21)17-6-3-2-4-7-17/h2-8,11-14,16,18H,9-10,15H2,1H3/t16-,18-/m1/s1 INHBZTGXXOKSJN-SJLPKXTDSA-N 426443 ((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl)(3- phenylpyridin-2-yl)methanone::US10526336, Example 62 Orexin/Hypocretin receptor type 1 Homo sapiens 3853 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426443&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439833 434320778 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859893 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C21H19F6N5O3/c1-12-4-5-13(35-18-16-30-9-15(21(25,26)27)31(16)8-7-29-18)10-32(12)19(33)14-3-2-6-28-17(14)34-11-20(22,23)24/h2-3,6-9,12-13H,4-5,10-11H2,1H3/t12-,13-/m1/s1 BZZPWDXPTWVWTG-CHWSQXEVSA-N 426444 ((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl) (2-(2,2,2-trifluoroethoxy)pyridin- 3-yl)methanone::US10526336, Example 63 Orexin receptor type 2 Homo sapiens 28.2 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426444&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439875 434320779 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859894 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C21H19F6N5O3/c1-12-4-5-13(35-18-16-30-9-15(21(25,26)27)31(16)8-7-29-18)10-32(12)19(33)14-3-2-6-28-17(14)34-11-20(22,23)24/h2-3,6-9,12-13H,4-5,10-11H2,1H3/t12-,13-/m1/s1 BZZPWDXPTWVWTG-CHWSQXEVSA-N 426444 ((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1-yl) (2-(2,2,2-trifluoroethoxy)pyridin- 3-yl)methanone::US10526336, Example 63 Orexin/Hypocretin receptor type 1 Homo sapiens 3309 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426444&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439875 434320779 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859895 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)F)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C21H20F5N5O3/c1-12-4-5-13(34-19-17-29-9-15(21(24,25)26)30(17)8-7-28-19)10-31(12)20(32)14-3-2-6-27-18(14)33-11-16(22)23/h2-3,6-9,12-13,16H,4-5,10-11H2,1H3/t12-,13-/m1/s1 RRBUYFQLRRJGAX-CHWSQXEVSA-N 426445 (2-(2,2- difluoroethoxy)pyridin- 3-yl)((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1- yl)methanone::US10526336, Example 64 Orexin receptor type 2 Homo sapiens 17.4 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426445&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439813 434320780 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859896 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)F)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C21H20F5N5O3/c1-12-4-5-13(34-19-17-29-9-15(21(24,25)26)30(17)8-7-28-19)10-31(12)20(32)14-3-2-6-27-18(14)33-11-16(22)23/h2-3,6-9,12-13,16H,4-5,10-11H2,1H3/t12-,13-/m1/s1 RRBUYFQLRRJGAX-CHWSQXEVSA-N 426445 (2-(2,2- difluoroethoxy)pyridin- 3-yl)((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1- yl)methanone::US10526336, Example 64 Orexin/Hypocretin receptor type 1 Homo sapiens 9998 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426445&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439813 434320780 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859897 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-n1cccn1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C22H20F3N7O2/c1-14-5-6-15(34-20-19-28-12-17(22(23,24)25)30(19)11-9-27-20)13-31(14)21(33)16-4-2-7-26-18(16)32-10-3-8-29-32/h2-4,7-12,14-15H,5-6,13H2,1H3/t14-,15-/m1/s1 XKLXYPZJASGHGH-HUUCEWRRSA-N 426446 (2-(1H-pyrazol-1- yl)pyridin-3-yl) ((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1- yl)methanone::US10526336, Example 65 Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426446&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439874 434320781 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859898 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-n1cccn1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C22H20F3N7O2/c1-14-5-6-15(34-20-19-28-12-17(22(23,24)25)30(19)11-9-27-20)13-31(14)21(33)16-4-2-7-26-18(16)32-10-3-8-29-32/h2-4,7-12,14-15H,5-6,13H2,1H3/t14-,15-/m1/s1 XKLXYPZJASGHGH-HUUCEWRRSA-N 426446 (2-(1H-pyrazol-1- yl)pyridin-3-yl) ((2R,5R)-2-methyl-5-((3- (trifluoromethyl)imidazo [1,2-alpha]pyrazin-8- yl)oxy)piperidin-1- yl)methanone::US10526336, Example 65 Orexin/Hypocretin receptor type 1 Homo sapiens 9326 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426446&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439874 434320781 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859899 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C24H21F3N6O2/c1-15-7-8-16(35-22-21-31-13-19(24(25,26)27)32(21)12-11-30-22)14-33(15)23(34)18-6-3-2-5-17(18)20-28-9-4-10-29-20/h2-6,9-13,15-16H,7-8,14H2,1H3/t15-,16-/m1/s1 SJYMAGKBDKVWTH-HZPDHXFCSA-N 426447 ((2R,5R)-2-methyl-5-((3-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US10526336, Example 66 Orexin receptor type 2 Homo sapiens 14.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426447&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439348 434320782 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859900 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1nccn2c(cnc12)C(F)(F)F InChI=1S/C24H21F3N6O2/c1-15-7-8-16(35-22-21-31-13-19(24(25,26)27)32(21)12-11-30-22)14-33(15)23(34)18-6-3-2-5-17(18)20-28-9-4-10-29-20/h2-6,9-13,15-16H,7-8,14H2,1H3/t15-,16-/m1/s1 SJYMAGKBDKVWTH-HZPDHXFCSA-N 426447 ((2R,5R)-2-methyl-5-((3-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)piperidin-1-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US10526336, Example 66 Orexin/Hypocretin receptor type 1 Homo sapiens 1234 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426447&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439348 434320782 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859901 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(cnc12)C(O)C(F)F InChI=1S/C23H23F2N7O3/c1-14-6-7-15(35-22-21-27-12-18(19(33)20(24)25)30(21)11-10-26-22)13-31(14)23(34)16-4-2-3-5-17(16)32-28-8-9-29-32/h2-5,8-12,14-15,19-20,33H,6-7,13H2,1H3/t14-,15-,19?/m1/s1 BZOWLQQGHOYKFO-YCQNMSHMSA-N 426448 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-(2,2-difluoro-1-hydroxyethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 67 Orexin receptor type 2 Homo sapiens 182 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426448&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439370 434320783 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859902 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(cnc12)C(O)C(F)F InChI=1S/C23H23F2N7O3/c1-14-6-7-15(35-22-21-27-12-18(19(33)20(24)25)30(21)11-10-26-22)13-31(14)23(34)16-4-2-3-5-17(16)32-28-8-9-29-32/h2-5,8-12,14-15,19-20,33H,6-7,13H2,1H3/t14-,15-,19?/m1/s1 BZOWLQQGHOYKFO-YCQNMSHMSA-N 426448 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-(2,2-difluoro-1-hydroxyethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 67 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426448&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439370 434320783 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859903 CC(O)c1cnc2c(O[C@@H]3CC[C@@H](C)N(C3)C(=O)c3ccccc3-n3nccn3)nccn12 InChI=1S/C23H25N7O3/c1-15-7-8-17(33-22-21-25-13-20(16(2)31)28(21)12-11-24-22)14-29(15)23(32)18-5-3-4-6-19(18)30-26-9-10-27-30/h3-6,9-13,15-17,31H,7-8,14H2,1-2H3/t15-,16?,17-/m1/s1 QDZASSNJWPYQSG-PWZMFNOBSA-N 426449 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-(1-hydroxyethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 68 Orexin receptor type 2 Homo sapiens 115 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426449&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439366 434320784 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859904 CC(O)c1cnc2c(O[C@@H]3CC[C@@H](C)N(C3)C(=O)c3ccccc3-n3nccn3)nccn12 InChI=1S/C23H25N7O3/c1-15-7-8-17(33-22-21-25-13-20(16(2)31)28(21)12-11-24-22)14-29(15)23(32)18-5-3-4-6-19(18)30-26-9-10-27-30/h3-6,9-13,15-17,31H,7-8,14H2,1-2H3/t15-,16?,17-/m1/s1 QDZASSNJWPYQSG-PWZMFNOBSA-N 426449 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-(1-hydroxyethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 68 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426449&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439366 434320784 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859905 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2nccc12 InChI=1S/C21H21N7O2/c1-15-6-7-16(30-20-19-8-9-23-27(19)13-12-22-20)14-26(15)21(29)17-4-2-3-5-18(17)28-24-10-11-25-28/h2-5,8-13,15-16H,6-7,14H2,1H3/t15-,16-/m1/s1 XTUBLGFHSMYMJF-HZPDHXFCSA-N 426450 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-yloxy)piperidin-1-yl)methanone::US10526336, Example 69 Orexin receptor type 2 Homo sapiens 26.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426450&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439369 434320785 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859906 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2nccc12 InChI=1S/C21H21N7O2/c1-15-6-7-16(30-20-19-8-9-23-27(19)13-12-22-20)14-26(15)21(29)17-4-2-3-5-18(17)28-24-10-11-25-28/h2-5,8-13,15-16H,6-7,14H2,1H3/t15-,16-/m1/s1 XTUBLGFHSMYMJF-HZPDHXFCSA-N 426450 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-yloxy)piperidin-1-yl)methanone::US10526336, Example 69 Orexin/Hypocretin receptor type 1 Homo sapiens 3073 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426450&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439369 434320785 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859907 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2nccc12 InChI=1S/C19H19N7O2S/c1-13-2-3-14(28-17-16-4-6-21-25(16)10-9-20-17)12-24(13)18(27)15-5-11-29-19(15)26-22-7-8-23-26/h4-11,13-14H,2-3,12H2,1H3/t13-,14-/m1/s1 ANAAXMVFQHWNOX-ZIAGYGMSSA-N 426451 (2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-yloxy)piperidin-1-yl)methanone::US10526336, Example 70 Orexin receptor type 2 Homo sapiens 9.80 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426451&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439362 434320786 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859908 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1nccn2nccc12 InChI=1S/C19H19N7O2S/c1-13-2-3-14(28-17-16-4-6-21-25(16)10-9-20-17)12-24(13)18(27)15-5-11-29-19(15)26-22-7-8-23-26/h4-11,13-14H,2-3,12H2,1H3/t13-,14-/m1/s1 ANAAXMVFQHWNOX-ZIAGYGMSSA-N 426451 (2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-yloxy)piperidin-1-yl)methanone::US10526336, Example 70 Orexin/Hypocretin receptor type 1 Homo sapiens 2208 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426451&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439362 434320786 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859909 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C19H19N7O2S/c1-13-2-3-14(28-18-17-20-6-8-24(17)9-7-21-18)10-25(13)19(27)15-11-29-12-16(15)26-22-4-5-23-26/h4-9,11-14H,2-3,10H2,1H3/t13-,14-/m1/s1 RCKFRNYPWUJDTQ-ZIAGYGMSSA-N 426452 (4-(2H-1,2,3-triazol-2-yl)thiophen-3- yl)((2R,5R)-2-methyl-5-(pyrazolo[1,5- alpha]pyrazin-4-yloxy)piperidin-1- yl)methanone::US10526336, Example 71::US10526336, Example 74 Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426452&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732927 434320787 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859910 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C19H19N7O2S/c1-13-2-3-14(28-18-17-20-6-8-24(17)9-7-21-18)10-25(13)19(27)15-11-29-12-16(15)26-22-4-5-23-26/h4-9,11-14H,2-3,10H2,1H3/t13-,14-/m1/s1 RCKFRNYPWUJDTQ-ZIAGYGMSSA-N 426452 (4-(2H-1,2,3-triazol-2-yl)thiophen-3- yl)((2R,5R)-2-methyl-5-(pyrazolo[1,5- alpha]pyrazin-4-yloxy)piperidin-1- yl)methanone::US10526336, Example 71::US10526336, Example 74 Orexin/Hypocretin receptor type 1 Homo sapiens 7278 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426452&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732927 434320787 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859911 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1nccn2ccnc12 InChI=1S/C23H23N5O2/c1-16-6-7-17(30-21-20-25-10-12-27(20)13-11-26-21)14-28(16)22(29)18-4-2-3-5-19(18)23(15-24)8-9-23/h2-5,10-13,16-17H,6-9,14H2,1H3/t16-,17-/m1/s1 ICANWASJWYMFKN-IAGOWNOFSA-N 426453 1-(2-((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4-yloxy) piperidine-1-carbonyl)phenyl) cyclopropanecarbonitrile::US10526336, Example 72 Orexin receptor type 2 Homo sapiens 14.3 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426453&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732928 434320788 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859912 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1nccn2ccnc12 InChI=1S/C23H23N5O2/c1-16-6-7-17(30-21-20-25-10-12-27(20)13-11-26-21)14-28(16)22(29)18-4-2-3-5-19(18)23(15-24)8-9-23/h2-5,10-13,16-17H,6-9,14H2,1H3/t16-,17-/m1/s1 ICANWASJWYMFKN-IAGOWNOFSA-N 426453 1-(2-((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4-yloxy) piperidine-1-carbonyl)phenyl) cyclopropanecarbonitrile::US10526336, Example 72 Orexin/Hypocretin receptor type 1 Homo sapiens 2673 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426453&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732928 434320788 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859913 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C21H20FN7O2/c1-14-2-4-16(31-20-19-23-8-10-27(19)11-9-24-20)13-28(14)21(30)17-5-3-15(22)12-18(17)29-25-6-7-26-29/h3,5-12,14,16H,2,4,13H2,1H3/t14-,16-/m1/s1 JBJGVHVMWXILCB-GDBMZVCRSA-N 426454 (4-fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4-yloxy)piperidin- 1-yl)methanone::US10526336, Example 73 Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426454&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732929 434320789 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859914 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C21H20FN7O2/c1-14-2-4-16(31-20-19-23-8-10-27(19)11-9-24-20)13-28(14)21(30)17-5-3-15(22)12-18(17)29-25-6-7-26-29/h3,5-12,14,16H,2,4,13H2,1H3/t14-,16-/m1/s1 JBJGVHVMWXILCB-GDBMZVCRSA-N 426454 (4-fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4-yloxy)piperidin- 1-yl)methanone::US10526336, Example 73 Orexin/Hypocretin receptor type 1 Homo sapiens 3752 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426454&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732929 434320789 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859915 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C19H19N7O2S/c1-13-2-3-14(28-18-17-20-6-8-24(17)9-7-21-18)10-25(13)19(27)15-11-29-12-16(15)26-22-4-5-23-26/h4-9,11-14H,2-3,10H2,1H3/t13-,14-/m1/s1 RCKFRNYPWUJDTQ-ZIAGYGMSSA-N 426452 (4-(2H-1,2,3-triazol-2-yl)thiophen-3- yl)((2R,5R)-2-methyl-5-(pyrazolo[1,5- alpha]pyrazin-4-yloxy)piperidin-1- yl)methanone::US10526336, Example 71::US10526336, Example 74 Orexin receptor type 2 Homo sapiens 34.4 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426452&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732927 434320787 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859916 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C19H19N7O2S/c1-13-2-3-14(28-18-17-20-6-8-24(17)9-7-21-18)10-25(13)19(27)15-11-29-12-16(15)26-22-4-5-23-26/h4-9,11-14H,2-3,10H2,1H3/t13-,14-/m1/s1 RCKFRNYPWUJDTQ-ZIAGYGMSSA-N 426452 (4-(2H-1,2,3-triazol-2-yl)thiophen-3- yl)((2R,5R)-2-methyl-5-(pyrazolo[1,5- alpha]pyrazin-4-yloxy)piperidin-1- yl)methanone::US10526336, Example 71::US10526336, Example 74 Orexin/Hypocretin receptor type 1 Homo sapiens 7495 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426452&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732927 434320787 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859917 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1nccn2ccnc12 InChI=1S/C21H20N6O2S/c1-14-3-4-15(29-20-19-24-8-10-26(19)11-9-25-20)13-27(14)21(28)16-5-12-30-17(16)18-22-6-2-7-23-18/h2,5-12,14-15H,3-4,13H2,1H3/t14-,15-/m1/s1 YVNBZCNMZNYMGL-HUUCEWRRSA-N 426456 ((2R,5R)-2-methyl-5-(pyrazolo[1,5- alpha]pyrazin-4-yloxy)piperidin-1-yl) (2-(pyrimidin-2-yl)thiophen-3-yl) methanone::US10526336, Example 75 Orexin receptor type 2 Homo sapiens 20.6 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426456&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732930 434320790 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859918 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1nccn2ccnc12 InChI=1S/C21H20N6O2S/c1-14-3-4-15(29-20-19-24-8-10-26(19)11-9-25-20)13-27(14)21(28)16-5-12-30-17(16)18-22-6-2-7-23-18/h2,5-12,14-15H,3-4,13H2,1H3/t14-,15-/m1/s1 YVNBZCNMZNYMGL-HUUCEWRRSA-N 426456 ((2R,5R)-2-methyl-5-(pyrazolo[1,5- alpha]pyrazin-4-yloxy)piperidin-1-yl) (2-(pyrimidin-2-yl)thiophen-3-yl) methanone::US10526336, Example 75 Orexin/Hypocretin receptor type 1 Homo sapiens 1767 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426456&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732930 434320790 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859919 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1nccn2ccnc12 InChI=1S/C20H20N8O2/c1-14-6-7-15(30-19-18-21-8-10-26(18)11-9-22-19)12-27(14)20(29)16-4-2-3-5-17(16)28-24-13-23-25-28/h2-5,8-11,13-15H,6-7,12H2,1H3/t14-,15-/m1/s1 WXSGZTXZZJEIKZ-HUUCEWRRSA-N 426457 (2-(2H-tetrazol-2-yl)phenyl)((2R,5R)- 2-methyl-5-(pyrazolo[1,5-alpha]pyrazin-4- yloxy)piperidin-1-yl)methanone::US10526336, Example 76 Orexin receptor type 2 Homo sapiens 27.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426457&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732931 434320791 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859920 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1nccn2ccnc12 InChI=1S/C20H20N8O2/c1-14-6-7-15(30-19-18-21-8-10-26(18)11-9-22-19)12-27(14)20(29)16-4-2-3-5-17(16)28-24-13-23-25-28/h2-5,8-11,13-15H,6-7,12H2,1H3/t14-,15-/m1/s1 WXSGZTXZZJEIKZ-HUUCEWRRSA-N 426457 (2-(2H-tetrazol-2-yl)phenyl)((2R,5R)- 2-methyl-5-(pyrazolo[1,5-alpha]pyrazin-4- yloxy)piperidin-1-yl)methanone::US10526336, Example 76 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426457&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732931 434320791 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859921 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2ccnc12 InChI=1S/C21H24N4O4S/c1-15-7-8-17(29-20-19-22-9-11-24(19)12-10-23-20)13-25(15)21(26)18-6-4-3-5-16(18)14-30(2,27)28/h3-6,9-12,15,17H,7-8,13-14H2,1-2H3/t15-,17-/m1/s1 SLCJVPQKKOFDDF-NVXWUHKLSA-N 426383 ((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)(2-((methylsulfonyl)methyl)phenyl)methanone::US10526336, Example 2::US10526336, Example 77 Orexin receptor type 2 Homo sapiens 27.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426383&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439336 434320722 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859922 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1nccn2ccnc12 InChI=1S/C21H24N4O4S/c1-15-7-8-17(29-20-19-22-9-11-24(19)12-10-23-20)13-25(15)21(26)18-6-4-3-5-16(18)14-30(2,27)28/h3-6,9-12,15,17H,7-8,13-14H2,1-2H3/t15-,17-/m1/s1 SLCJVPQKKOFDDF-NVXWUHKLSA-N 426383 ((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)(2-((methylsulfonyl)methyl)phenyl)methanone::US10526336, Example 2::US10526336, Example 77 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426383&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439336 434320722 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859923 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-c1ccccn1)Oc1nccn2ccnc12 InChI=1S/C22H21N7O2/c1-15-5-6-16(31-21-20-26-10-12-28(20)13-11-27-21)14-29(15)22(30)19-18(24-8-9-25-19)17-4-2-3-7-23-17/h2-4,7-13,15-16H,5-6,14H2,1H3/t15-,16-/m1/s1 KQUNVDFGWZXXKJ-HZPDHXFCSA-N 426459 ((2R,5R)-2-methyl-5-(pyrazolo[1,5- alpha]pyrazin-4-yloxy)piperidin-1-yl)(3- (pyridin-2-yl)pyrazin-2-yl)methanone::US10526336, Example 78 Orexin receptor type 2 Homo sapiens 59.1 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426459&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732932 434320792 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859924 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-c1ccccn1)Oc1nccn2ccnc12 InChI=1S/C22H21N7O2/c1-15-5-6-16(31-21-20-26-10-12-28(20)13-11-27-21)14-29(15)22(30)19-18(24-8-9-25-19)17-4-2-3-7-23-17/h2-4,7-13,15-16H,5-6,14H2,1H3/t15-,16-/m1/s1 KQUNVDFGWZXXKJ-HZPDHXFCSA-N 426459 ((2R,5R)-2-methyl-5-(pyrazolo[1,5- alpha]pyrazin-4-yloxy)piperidin-1-yl)(3- (pyridin-2-yl)pyrazin-2-yl)methanone::US10526336, Example 78 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426459&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732932 434320792 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859925 COC(=O)c1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C21H22N4O4/c1-14-7-8-15(29-19-18-22-9-11-24(18)12-10-23-19)13-25(14)20(26)16-5-3-4-6-17(16)21(27)28-2/h3-6,9-12,14-15H,7-8,13H2,1-2H3/t14-,15-/m1/s1 FHZTYHNAIWVNBX-HUUCEWRRSA-N 426460 US10526336, Example 79::methyl 2-((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4- yloxy)piperidine-1-carbonyl)benzoate Orexin receptor type 2 Homo sapiens 44.2 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426460&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732933 434320793 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859926 COC(=O)c1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C21H22N4O4/c1-14-7-8-15(29-19-18-22-9-11-24(18)12-10-23-19)13-25(14)20(26)16-5-3-4-6-17(16)21(27)28-2/h3-6,9-12,14-15H,7-8,13H2,1-2H3/t14-,15-/m1/s1 FHZTYHNAIWVNBX-HUUCEWRRSA-N 426460 US10526336, Example 79::methyl 2-((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4- yloxy)piperidine-1-carbonyl)benzoate Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426460&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732933 434320793 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859927 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C19H19N9O2/c1-13-2-3-14(30-18-17-22-8-10-26(17)11-9-23-18)12-27(13)19(29)15-16(21-5-4-20-15)28-24-6-7-25-28/h4-11,13-14H,2-3,12H2,1H3/t13-,14-/m1/s1 SFBTXLBGGVSGEA-ZIAGYGMSSA-N 426461 (3-(1H-pyrazol-1-yl)pyrazin-2-yl)((2R,5R)- 2-methyl-5-(pyrazolo[1,5-alpha]pyrazin-4- yloxy)piperidin-1-yl)methanone::US10526336, Example 80 Orexin receptor type 2 Homo sapiens 31.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426461&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732934 434320794 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859928 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-n1nccn1)Oc1nccn2ccnc12 InChI=1S/C19H19N9O2/c1-13-2-3-14(30-18-17-22-8-10-26(17)11-9-23-18)12-27(13)19(29)15-16(21-5-4-20-15)28-24-6-7-25-28/h4-11,13-14H,2-3,12H2,1H3/t13-,14-/m1/s1 SFBTXLBGGVSGEA-ZIAGYGMSSA-N 426461 (3-(1H-pyrazol-1-yl)pyrazin-2-yl)((2R,5R)- 2-methyl-5-(pyrazolo[1,5-alpha]pyrazin-4- yloxy)piperidin-1-yl)methanone::US10526336, Example 80 Orexin/Hypocretin receptor type 1 Homo sapiens 3524 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426461&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732934 434320794 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859929 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C21H24N4O3/c1-3-27-18-7-5-4-6-17(18)21(26)25-14-16(9-8-15(25)2)28-20-19-22-10-12-24(19)13-11-23-20/h4-7,10-13,15-16H,3,8-9,14H2,1-2H3/t15-,16-/m1/s1 LHHXJJBVPJTVPY-HZPDHXFCSA-N 426462 (2-ethoxyphenyl)((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4-yloxy)piperidin- 1-yl)methanone::US10526336, Example 81 Orexin receptor type 2 Homo sapiens 51.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426462&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732935 434320795 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859930 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C21H24N4O3/c1-3-27-18-7-5-4-6-17(18)21(26)25-14-16(9-8-15(25)2)28-20-19-22-10-12-24(19)13-11-23-20/h4-7,10-13,15-16H,3,8-9,14H2,1-2H3/t15-,16-/m1/s1 LHHXJJBVPJTVPY-HZPDHXFCSA-N 426462 (2-ethoxyphenyl)((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4-yloxy)piperidin- 1-yl)methanone::US10526336, Example 81 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426462&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732935 434320795 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859931 CCCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C22H26N4O2/c1-3-6-17-7-4-5-8-19(17)22(27)26-15-18(10-9-16(26)2)28-21-20-23-11-13-25(20)14-12-24-21/h4-5,7-8,11-14,16,18H,3,6,9-10,15H2,1-2H3/t16-,18-/m1/s1 VOEWZRYXNLDWCT-SJLPKXTDSA-N 426385 ((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)(2-propylphenyl)methanone::US10526336, Example 4::US10526336, Example 82 Orexin receptor type 2 Homo sapiens 33.9 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426385&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439352 434320724 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859932 CCCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C22H26N4O2/c1-3-6-17-7-4-5-8-19(17)22(27)26-15-18(10-9-16(26)2)28-21-20-23-11-13-25(20)14-12-24-21/h4-5,7-8,11-14,16,18H,3,6,9-10,15H2,1-2H3/t16-,18-/m1/s1 VOEWZRYXNLDWCT-SJLPKXTDSA-N 426385 ((2R,5R)-5-(imidazo[1,2-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)(2-propylphenyl)methanone::US10526336, Example 4::US10526336, Example 82 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426385&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439352 434320724 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859933 CC(C)Oc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C21H25N5O3/c1-14(2)28-19-17(5-4-8-23-19)21(27)26-13-16(7-6-15(26)3)29-20-18-22-9-11-25(18)12-10-24-20/h4-5,8-12,14-16H,6-7,13H2,1-3H3/t15-,16-/m1/s1 YWMPRYQVLNCAKX-HZPDHXFCSA-N 426464 (2-isopropoxypyridin-3-yl)((2R,5R)- 2-methyl-5-(pyrazolo[1,5-alpha]pyrazin-4- yloxy)piperidin-1-yl)methanone::US10526336, Example 83 Orexin receptor type 2 Homo sapiens 49.1 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426464&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732936 434320796 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859934 CC(C)Oc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C21H25N5O3/c1-14(2)28-19-17(5-4-8-23-19)21(27)26-13-16(7-6-15(26)3)29-20-18-22-9-11-25(18)12-10-24-20/h4-5,8-12,14-16H,6-7,13H2,1-3H3/t15-,16-/m1/s1 YWMPRYQVLNCAKX-HZPDHXFCSA-N 426464 (2-isopropoxypyridin-3-yl)((2R,5R)- 2-methyl-5-(pyrazolo[1,5-alpha]pyrazin-4- yloxy)piperidin-1-yl)methanone::US10526336, Example 83 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426464&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732936 434320796 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859935 CC(C)Oc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C22H26N4O3/c1-15(2)28-19-7-5-4-6-18(19)22(27)26-14-17(9-8-16(26)3)29-21-20-23-10-12-25(20)13-11-24-21/h4-7,10-13,15-17H,8-9,14H2,1-3H3/t16-,17-/m1/s1 RHENKEMLEAGILR-IAGOWNOFSA-N 426465 (2-isopropoxyphenyl)((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4-yloxy)piperidin- 1-yl)methanone::US10526336, Example 84 Orexin receptor type 2 Homo sapiens 43.5 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426465&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 154732937 434320797 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859936 CC(C)Oc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1nccn2ccnc12 InChI=1S/C22H26N4O3/c1-15(2)28-19-7-5-4-6-18(19)22(27)26-14-17(9-8-16(26)3)29-21-20-23-10-12-25(20)13-11-24-21/h4-7,10-13,15-17H,8-9,14H2,1-3H3/t16-,17-/m1/s1 RHENKEMLEAGILR-IAGOWNOFSA-N 426465 (2-isopropoxyphenyl)((2R,5R)-2-methyl-5- (pyrazolo[1,5-alpha]pyrazin-4-yloxy)piperidin- 1-yl)methanone::US10526336, Example 84 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426465&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 154732937 434320797 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859937 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1nccn2nccc12 InChI=1S/C23H22N6O2/c1-16-7-8-17(31-22-20-9-12-27-29(20)14-13-26-22)15-28(16)23(30)19-6-3-2-5-18(19)21-24-10-4-11-25-21/h2-6,9-14,16-17H,7-8,15H2,1H3/t16-,17-/m1/s1 HSJPFTYVSRGKPB-IAGOWNOFSA-N 426466 ((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-yloxy)piperidin-1-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US10526336, Example 85 Orexin receptor type 2 Homo sapiens 15.5 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426466&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439338 434320798 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859938 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1nccn2nccc12 InChI=1S/C23H22N6O2/c1-16-7-8-17(31-22-20-9-12-27-29(20)14-13-26-22)15-28(16)23(30)19-6-3-2-5-18(19)21-24-10-4-11-25-21/h2-6,9-14,16-17H,7-8,15H2,1H3/t16-,17-/m1/s1 HSJPFTYVSRGKPB-IAGOWNOFSA-N 426466 ((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-yloxy)piperidin-1-yl)(2-(pyrimidin-2-yl)phenyl)methanone::US10526336, Example 85 Orexin/Hypocretin receptor type 1 Homo sapiens 1498 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426466&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439338 434320798 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859939 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccn2nccc12 InChI=1S/C21H22N8O/c1-15-6-7-16(26-20-19-8-9-23-28(19)13-12-22-20)14-27(15)21(30)17-4-2-3-5-18(17)29-24-10-11-25-29/h2-5,8-13,15-16H,6-7,14H2,1H3,(H,22,26)/t15-,16-/m1/s1 MDPBVUIHWMLXCY-HZPDHXFCSA-N 426467 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-ylamino)piperidin-1-yl)methanone::US10526336, Example 86 Orexin receptor type 2 Homo sapiens 20.5 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426467&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439355 434320799 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859940 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccn2nccc12 InChI=1S/C21H22N8O/c1-15-6-7-16(26-20-19-8-9-23-28(19)13-12-22-20)14-27(15)21(30)17-4-2-3-5-18(17)29-24-10-11-25-29/h2-5,8-13,15-16H,6-7,14H2,1H3,(H,22,26)/t15-,16-/m1/s1 MDPBVUIHWMLXCY-HZPDHXFCSA-N 426467 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-ylamino)piperidin-1-yl)methanone::US10526336, Example 86 Orexin/Hypocretin receptor type 1 Homo sapiens 2753 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426467&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439355 434320799 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859941 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Sc1nccn2nccc12 InChI=1S/C21H21N7OS/c1-15-6-7-16(30-20-19-8-9-23-27(19)13-12-22-20)14-26(15)21(29)17-4-2-3-5-18(17)28-24-10-11-25-28/h2-5,8-13,15-16H,6-7,14H2,1H3/t15-,16-/m1/s1 JQSGSZIMQBSLDT-HZPDHXFCSA-N 426468 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-ylthio)piperidin-1-yl)methanone::US10526336, Example 87 Orexin receptor type 2 Homo sapiens 15.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426468&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439363 434320800 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859942 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Sc1nccn2nccc12 InChI=1S/C21H21N7OS/c1-15-6-7-16(30-20-19-8-9-23-27(19)13-12-22-20)14-26(15)21(29)17-4-2-3-5-18(17)28-24-10-11-25-28/h2-5,8-13,15-16H,6-7,14H2,1H3/t15-,16-/m1/s1 JQSGSZIMQBSLDT-HZPDHXFCSA-N 426468 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyrazin-4-ylthio)piperidin-1-yl)methanone::US10526336, Example 87 Orexin/Hypocretin receptor type 1 Homo sapiens 830 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426468&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439363 434320800 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859943 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2ncc(Br)c12 InChI=1S/C21H20BrN7O2/c1-14-6-7-15(31-20-19-17(22)12-26-28(19)11-10-23-20)13-27(14)21(30)16-4-2-3-5-18(16)29-24-8-9-25-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 QGKVTTIWNNLPNC-HUUCEWRRSA-N 426469 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-bromopyrazolo[1,5-a]pyrazin-4-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 88 Orexin receptor type 2 Homo sapiens 7.30 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426469&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439379 434320801 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859944 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2ncc(Br)c12 InChI=1S/C21H20BrN7O2/c1-14-6-7-15(31-20-19-17(22)12-26-28(19)11-10-23-20)13-27(14)21(30)16-4-2-3-5-18(16)29-24-8-9-25-29/h2-5,8-12,14-15H,6-7,13H2,1H3/t14-,15-/m1/s1 QGKVTTIWNNLPNC-HUUCEWRRSA-N 426469 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-bromopyrazolo[1,5-a]pyrazin-4-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 88 Orexin/Hypocretin receptor type 1 Homo sapiens 512 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426469&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439379 434320801 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859945 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2ncc(C)c12 InChI=1S/C22H23N7O2/c1-15-13-26-28-12-11-23-21(20(15)28)31-17-8-7-16(2)27(14-17)22(30)18-5-3-4-6-19(18)29-24-9-10-25-29/h3-6,9-13,16-17H,7-8,14H2,1-2H3/t16-,17-/m1/s1 AHONSBIUOSQTKE-IAGOWNOFSA-N 426472 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methylpyrazolo[1,5-a]pyrazin-4-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 89 Orexin receptor type 2 Homo sapiens 19.2 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426472&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439353 434320803 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859946 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2ncc(C)c12 InChI=1S/C22H23N7O2/c1-15-13-26-28-12-11-23-21(20(15)28)31-17-8-7-16(2)27(14-17)22(30)18-5-3-4-6-19(18)29-24-9-10-25-29/h3-6,9-13,16-17H,7-8,14H2,1-2H3/t16-,17-/m1/s1 AHONSBIUOSQTKE-IAGOWNOFSA-N 426472 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methylpyrazolo[1,5-a]pyrazin-4-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 89 Orexin/Hypocretin receptor type 1 Homo sapiens 938 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426472&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439353 434320803 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859947 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cccn2nccc12 InChI=1S/C22H22N6O2/c1-16-8-9-17(30-21-7-4-14-27-20(21)10-11-23-27)15-26(16)22(29)18-5-2-3-6-19(18)28-24-12-13-25-28/h2-7,10-14,16-17H,8-9,15H2,1H3/t16-,17-/m1/s1 APHHVSDDYQSFNG-IAGOWNOFSA-N 426473 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyridin-4-yloxy)piperidin-1-yl)methanone::US10526336, Example 90 Orexin receptor type 2 Homo sapiens 125 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426473&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439360 434320804 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859948 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cccn2nccc12 InChI=1S/C22H22N6O2/c1-16-8-9-17(30-21-7-4-14-27-20(21)10-11-23-27)15-26(16)22(29)18-5-2-3-6-19(18)28-24-12-13-25-28/h2-7,10-14,16-17H,8-9,15H2,1H3/t16-,17-/m1/s1 APHHVSDDYQSFNG-IAGOWNOFSA-N 426473 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(pyrazolo[1,5-a]pyridin-4-yloxy)piperidin-1-yl)methanone::US10526336, Example 90 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426473&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439360 434320804 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859949 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1ccnc2ocnc12 InChI=1S/C21H20N6O3/c1-14-6-7-15(30-18-8-9-22-20-19(18)23-13-29-20)12-26(14)21(28)16-4-2-3-5-17(16)27-24-10-11-25-27/h2-5,8-11,13-15H,6-7,12H2,1H3/t14-,15-/m1/s1 MDTDILUTVOTHRE-HUUCEWRRSA-N 426474 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(oxazolo[5,4-b]pyridin-7-yloxy)piperidin-1-yl)methanone::US10526336, Example 91 Orexin receptor type 2 Homo sapiens 16.3 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426474&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439354 434320805 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859950 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1ccnc2ocnc12 InChI=1S/C21H20N6O3/c1-14-6-7-15(30-18-8-9-22-20-19(18)23-13-29-20)12-26(14)21(28)16-4-2-3-5-17(16)27-24-10-11-25-27/h2-5,8-11,13-15H,6-7,12H2,1H3/t14-,15-/m1/s1 MDTDILUTVOTHRE-HUUCEWRRSA-N 426474 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(oxazolo[5,4-b]pyridin-7-yloxy)piperidin-1-yl)methanone::US10526336, Example 91 Orexin/Hypocretin receptor type 1 Homo sapiens 991 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426474&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439354 434320805 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859951 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1ccnc2ocnc12 InChI=1S/C20H19N7O3/c1-13-6-7-14(30-17-8-9-21-19-18(17)22-12-29-19)10-26(13)20(28)15-4-2-3-5-16(15)27-24-11-23-25-27/h2-5,8-9,11-14H,6-7,10H2,1H3/t13-,14-/m1/s1 WRSBGKRWXHJPKB-ZIAGYGMSSA-N 426475 (2-(2H-tetrazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(oxazolo [5,4-b]pyridin-7-yloxy)piperidin-1-yl)methanone::US10526336, Example 92 Orexin receptor type 2 Homo sapiens 36.7 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426475&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439334 434320806 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859952 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1ccnc2ocnc12 InChI=1S/C20H19N7O3/c1-13-6-7-14(30-17-8-9-21-19-18(17)22-12-29-19)10-26(13)20(28)15-4-2-3-5-16(15)27-24-11-23-25-27/h2-5,8-9,11-14H,6-7,10H2,1H3/t13-,14-/m1/s1 WRSBGKRWXHJPKB-ZIAGYGMSSA-N 426475 (2-(2H-tetrazol-2-yl)phenyl)((2R,5R)-2-methyl-5-(oxazolo [5,4-b]pyridin-7-yloxy)piperidin-1-yl)methanone::US10526336, Example 92 Orexin/Hypocretin receptor type 1 Homo sapiens 3133 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426475&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439334 434320806 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859953 COC(=O)c1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1ccnc2ocnc12 InChI=1S/C21H21N3O5/c1-13-7-8-14(29-17-9-10-22-19-18(17)23-12-28-19)11-24(13)20(25)15-5-3-4-6-16(15)21(26)27-2/h3-6,9-10,12-14H,7-8,11H2,1-2H3/t13-,14-/m1/s1 YMXDWLYKOPDIFJ-ZIAGYGMSSA-N 426476 US10526336, Example 93::methyl 2-((2R,5R)-2- methyl-5-(oxazolo[5,4- b]pyridin-7- yloxy)piperidine-1- carbonyl)benzoate Orexin receptor type 2 Homo sapiens 46.4 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426476&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439817 434320807 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859954 COC(=O)c1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1ccnc2ocnc12 InChI=1S/C21H21N3O5/c1-13-7-8-14(29-17-9-10-22-19-18(17)23-12-28-19)11-24(13)20(25)15-5-3-4-6-16(15)21(26)27-2/h3-6,9-10,12-14H,7-8,11H2,1-2H3/t13-,14-/m1/s1 YMXDWLYKOPDIFJ-ZIAGYGMSSA-N 426476 US10526336, Example 93::methyl 2-((2R,5R)-2- methyl-5-(oxazolo[5,4- b]pyridin-7- yloxy)piperidine-1- carbonyl)benzoate Orexin/Hypocretin receptor type 1 Homo sapiens 3200 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426476&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439817 434320807 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859955 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1ccnc2ocnc12 InChI=1S/C21H23N3O4/c1-3-26-17-7-5-4-6-16(17)21(25)24-12-15(9-8-14(24)2)28-18-10-11-22-20-19(18)23-13-27-20/h4-7,10-11,13-15H,3,8-9,12H2,1-2H3/t14-,15-/m1/s1 RYYMOGIVOKFLFF-HUUCEWRRSA-N 426477 (2-ethoxyphenyl)((2R,5R)- 2-methyl-5- (oxazolo[5,4-b]pyridin- 7-yloxy)piperidin-1- yl)methanone::US10526336, Example 94 Orexin receptor type 2 Homo sapiens 24.4 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426477&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439843 434320808 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859956 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1ccnc2ocnc12 InChI=1S/C21H23N3O4/c1-3-26-17-7-5-4-6-16(17)21(25)24-12-15(9-8-14(24)2)28-18-10-11-22-20-19(18)23-13-27-20/h4-7,10-11,13-15H,3,8-9,12H2,1-2H3/t14-,15-/m1/s1 RYYMOGIVOKFLFF-HUUCEWRRSA-N 426477 (2-ethoxyphenyl)((2R,5R)- 2-methyl-5- (oxazolo[5,4-b]pyridin- 7-yloxy)piperidin-1- yl)methanone::US10526336, Example 94 Orexin/Hypocretin receptor type 1 Homo sapiens 2158 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426477&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439843 434320808 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859957 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2n(C)ncc12 InChI=1S/C22H23N7O2/c1-15-7-8-16(31-21-18-13-26-27(2)19(18)9-10-23-21)14-28(15)22(30)17-5-3-4-6-20(17)29-24-11-12-25-29/h3-6,9-13,15-16H,7-8,14H2,1-2H3/t15-,16-/m1/s1 OMWFJVSWUVZEEW-HZPDHXFCSA-N 426478 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((1-methyl-1H-pyrazolo[4,3-c]pyridin-4-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 95 Orexin receptor type 2 Homo sapiens 17.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426478&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439384 434320809 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859958 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2n(C)ncc12 InChI=1S/C22H23N7O2/c1-15-7-8-16(31-21-18-13-26-27(2)19(18)9-10-23-21)14-28(15)22(30)17-5-3-4-6-20(17)29-24-11-12-25-29/h3-6,9-13,15-16H,7-8,14H2,1-2H3/t15-,16-/m1/s1 OMWFJVSWUVZEEW-HZPDHXFCSA-N 426478 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((1-methyl-1H-pyrazolo[4,3-c]pyridin-4-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 95 Orexin/Hypocretin receptor type 1 Homo sapiens 2308 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426478&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439384 434320809 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859959 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccc2n(C)ncc12 InChI=1S/C22H24N8O/c1-15-7-8-16(27-21-18-13-26-28(2)19(18)9-10-23-21)14-29(15)22(31)17-5-3-4-6-20(17)30-24-11-12-25-30/h3-6,9-13,15-16H,7-8,14H2,1-2H3,(H,23,27)/t15-,16-/m1/s1 SUKVRFSDOQPLHL-HZPDHXFCSA-N 426479 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((1-methyl-1H-pyrazolo[4,3-c]pyridin-4-yl)amino)piperidin-1-yl)methanone::US10526336, Example 96 Orexin receptor type 2 Homo sapiens 60.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426479&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439344 434320810 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859960 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccc2n(C)ncc12 InChI=1S/C22H24N8O/c1-15-7-8-16(27-21-18-13-26-28(2)19(18)9-10-23-21)14-29(15)22(31)17-5-3-4-6-20(17)30-24-11-12-25-30/h3-6,9-13,15-16H,7-8,14H2,1-2H3,(H,23,27)/t15-,16-/m1/s1 SUKVRFSDOQPLHL-HZPDHXFCSA-N 426479 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((1-methyl-1H-pyrazolo[4,3-c]pyridin-4-yl)amino)piperidin-1-yl)methanone::US10526336, Example 96 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426479&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439344 434320810 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859961 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccc2nn(C)cc12 InChI=1S/C22H24N8O/c1-15-7-8-16(26-21-18-14-28(2)27-19(18)9-10-23-21)13-29(15)22(31)17-5-3-4-6-20(17)30-24-11-12-25-30/h3-6,9-12,14-16H,7-8,13H2,1-2H3,(H,23,26)/t15-,16-/m1/s1 AHARNFMCBZDTFA-HZPDHXFCSA-N 426482 (2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)- 2-methyl- 5-((2-methyl-2H- pyrazolo[4,3-c]pyridin- 4-yl)amino) piperidin-1-yl) methanone::US10526336, Example 97 Orexin receptor type 2 Homo sapiens 124 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426482&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439842 434320813 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859962 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccc2nn(C)cc12 InChI=1S/C22H24N8O/c1-15-7-8-16(26-21-18-14-28(2)27-19(18)9-10-23-21)13-29(15)22(31)17-5-3-4-6-20(17)30-24-11-12-25-30/h3-6,9-12,14-16H,7-8,13H2,1-2H3,(H,23,26)/t15-,16-/m1/s1 AHARNFMCBZDTFA-HZPDHXFCSA-N 426482 (2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)- 2-methyl- 5-((2-methyl-2H- pyrazolo[4,3-c]pyridin- 4-yl)amino) piperidin-1-yl) methanone::US10526336, Example 97 Orexin/Hypocretin receptor type 1 Homo sapiens 6625 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426482&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439842 434320813 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859963 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2n(C)cnc12 InChI=1S/C22H23N7O2/c1-15-7-8-16(31-21-20-19(9-10-23-21)27(2)14-24-20)13-28(15)22(30)17-5-3-4-6-18(17)29-25-11-12-26-29/h3-6,9-12,14-16H,7-8,13H2,1-2H3/t15-,16-/m1/s1 PVHZNQMNBWCUEQ-HZPDHXFCSA-N 426483 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((1-methyl-1H-imidazo[4,5-c]pyridin-4-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 98 Orexin receptor type 2 Homo sapiens 28.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426483&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439328 434320814 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859964 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2n(C)cnc12 InChI=1S/C22H23N7O2/c1-15-7-8-16(31-21-20-19(9-10-23-21)27(2)14-24-20)13-28(15)22(30)17-5-3-4-6-18(17)29-25-11-12-26-29/h3-6,9-12,14-16H,7-8,13H2,1-2H3/t15-,16-/m1/s1 PVHZNQMNBWCUEQ-HZPDHXFCSA-N 426483 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((1-methyl-1H-imidazo[4,5-c]pyridin-4-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 98 Orexin/Hypocretin receptor type 1 Homo sapiens 3101 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426483&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439328 434320814 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859965 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2ncn(C)c12 InChI=1S/C22H23N7O2/c1-15-7-8-16(31-21-20-18(9-10-23-21)24-14-27(20)2)13-28(15)22(30)17-5-3-4-6-19(17)29-25-11-12-26-29/h3-6,9-12,14-16H,7-8,13H2,1-2H3/t15-,16-/m1/s1 DDJYMJOBUIQBMK-HZPDHXFCSA-N 426484 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methyl-3H-imidazo[4,5-c]pyridin-4-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 99 Orexin receptor type 2 Homo sapiens 42.3 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426484&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439373 434320815 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859966 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2ncn(C)c12 InChI=1S/C22H23N7O2/c1-15-7-8-16(31-21-20-18(9-10-23-21)24-14-27(20)2)13-28(15)22(30)17-5-3-4-6-19(17)29-25-11-12-26-29/h3-6,9-12,14-16H,7-8,13H2,1-2H3/t15-,16-/m1/s1 DDJYMJOBUIQBMK-HZPDHXFCSA-N 426484 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methyl-3H-imidazo[4,5-c]pyridin-4-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 99 Orexin/Hypocretin receptor type 1 Homo sapiens 8102 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426484&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439373 434320815 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859967 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccc2ncn(C)c12 InChI=1S/C22H24N8O/c1-15-7-8-16(27-21-20-18(9-10-23-21)24-14-28(20)2)13-29(15)22(31)17-5-3-4-6-19(17)30-25-11-12-26-30/h3-6,9-12,14-16H,7-8,13H2,1-2H3,(H,23,27)/t15-,16-/m1/s1 FYCCCWUZAAKUEB-HZPDHXFCSA-N 426485 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methyl-3H-imidazo[4,5-c]pyridin-4-yl)amino)piperidin-1-yl)methanone::US10526336, Example 100 Orexin receptor type 2 Homo sapiens 95.8 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426485&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439371 434320816 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859968 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccc2ncn(C)c12 InChI=1S/C22H24N8O/c1-15-7-8-16(27-21-20-18(9-10-23-21)24-14-28(20)2)13-29(15)22(31)17-5-3-4-6-19(17)30-25-11-12-26-30/h3-6,9-12,14-16H,7-8,13H2,1-2H3,(H,23,27)/t15-,16-/m1/s1 FYCCCWUZAAKUEB-HZPDHXFCSA-N 426485 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methyl-3H-imidazo[4,5-c]pyridin-4-yl)amino)piperidin-1-yl)methanone::US10526336, Example 100 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426485&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439371 434320816 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859969 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccc2n(C)cnc12 InChI=1S/C22H24N8O/c1-15-7-8-16(27-21-20-19(9-10-23-21)28(2)14-24-20)13-29(15)22(31)17-5-3-4-6-18(17)30-25-11-12-26-30/h3-6,9-12,14-16H,7-8,13H2,1-2H3,(H,23,27)/t15-,16-/m1/s1 MQJIHEABNJLSAF-HZPDHXFCSA-N 426486 (2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-2-methyl- 5-((1-methyl-1H-imidazo[4,5- c]pyridin-4-yl)amino)piperidin- 1-yl)methanone::US10526336, Example 101 Orexin receptor type 2 Homo sapiens 38.5 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426486&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439820 434320817 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859970 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Nc1nccc2n(C)cnc12 InChI=1S/C22H24N8O/c1-15-7-8-16(27-21-20-19(9-10-23-21)28(2)14-24-20)13-29(15)22(31)17-5-3-4-6-18(17)30-25-11-12-26-30/h3-6,9-12,14-16H,7-8,13H2,1-2H3,(H,23,27)/t15-,16-/m1/s1 MQJIHEABNJLSAF-HZPDHXFCSA-N 426486 (2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-2-methyl- 5-((1-methyl-1H-imidazo[4,5- c]pyridin-4-yl)amino)piperidin- 1-yl)methanone::US10526336, Example 101 Orexin/Hypocretin receptor type 1 Homo sapiens 9263 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426486&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439820 434320817 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859971 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cncc12 InChI=1S/C21H21N7O2/c1-15-6-7-16(30-20-19-12-22-14-26(19)11-10-23-20)13-27(15)21(29)17-4-2-3-5-18(17)28-24-8-9-25-28/h2-5,8-12,14-16H,6-7,13H2,1H3/t15-,16-/m1/s1 PETSBWHXOSNGNM-HZPDHXFCSA-N 426487 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-(imidazo[1,5-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 102 Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426487&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439357 434320818 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859972 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2cncc12 InChI=1S/C21H21N7O2/c1-15-6-7-16(30-20-19-12-22-14-26(19)11-10-23-20)13-27(15)21(29)17-4-2-3-5-18(17)28-24-8-9-25-28/h2-5,8-12,14-16H,6-7,13H2,1H3/t15-,16-/m1/s1 PETSBWHXOSNGNM-HZPDHXFCSA-N 426487 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-(imidazo[1,5-a]pyrazin-8-yloxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 102 Orexin/Hypocretin receptor type 1 Homo sapiens 9245 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426487&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439357 434320818 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859973 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(C)ncc12 InChI=1S/C22H23N7O2/c1-15-7-8-17(31-21-20-13-24-16(2)27(20)12-11-23-21)14-28(15)22(30)18-5-3-4-6-19(18)29-25-9-10-26-29/h3-6,9-13,15,17H,7-8,14H2,1-2H3/t15-,17-/m1/s1 JBDYZUFMEFQACH-NVXWUHKLSA-N 426488 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methylimidazo[1,5-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 103 Orexin receptor type 2 Homo sapiens 23.5 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426488&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439330 434320819 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859974 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(C)ncc12 InChI=1S/C22H23N7O2/c1-15-7-8-17(31-21-20-13-24-16(2)27(20)12-11-23-21)14-28(15)22(30)18-5-3-4-6-19(18)29-25-9-10-26-29/h3-6,9-13,15,17H,7-8,14H2,1-2H3/t15-,17-/m1/s1 JBDYZUFMEFQACH-NVXWUHKLSA-N 426488 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((3-methylimidazo[1,5-a]pyrazin-8-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 103 Orexin/Hypocretin receptor type 1 Homo sapiens 2436 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426488&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439330 434320819 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859975 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2nc(C)nn12 InChI=1S/C21H22N8O2/c1-14-7-8-16(31-21-22-10-9-19-25-15(2)26-28(19)21)13-27(14)20(30)17-5-3-4-6-18(17)29-23-11-12-24-29/h3-6,9-12,14,16H,7-8,13H2,1-2H3/t14-,16-/m1/s1 CYSKASVYURZNFQ-GDBMZVCRSA-N 426489 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methyl-[1,2,4]triazolo[1,5-c]pyrimidin-5-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 104::US10526336, Example 105 Orexin receptor type 2 Homo sapiens 60.0 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426489&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439342 434320820 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859976 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2nc(C)nn12 InChI=1S/C21H22N8O2/c1-14-7-8-16(31-21-22-10-9-19-25-15(2)26-28(19)21)13-27(14)20(30)17-5-3-4-6-18(17)29-23-11-12-24-29/h3-6,9-12,14,16H,7-8,13H2,1-2H3/t14-,16-/m1/s1 CYSKASVYURZNFQ-GDBMZVCRSA-N 426489 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methyl-[1,2,4]triazolo[1,5-c]pyrimidin-5-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 104::US10526336, Example 105 Orexin/Hypocretin receptor type 1 Homo sapiens 9140 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426489&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439342 434320820 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859977 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2nc(C)nn12 InChI=1S/C21H22N8O2/c1-14-7-8-16(31-21-22-10-9-19-25-15(2)26-28(19)21)13-27(14)20(30)17-5-3-4-6-18(17)29-23-11-12-24-29/h3-6,9-12,14,16H,7-8,13H2,1-2H3/t14-,16-/m1/s1 CYSKASVYURZNFQ-GDBMZVCRSA-N 426489 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methyl-[1,2,4]triazolo[1,5-c]pyrimidin-5-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 104::US10526336, Example 105 Orexin receptor type 2 Homo sapiens 27.6 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426489&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439342 434320820 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859978 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccc2nc(C)nn12 InChI=1S/C21H22N8O2/c1-14-7-8-16(31-21-22-10-9-19-25-15(2)26-28(19)21)13-27(14)20(30)17-5-3-4-6-18(17)29-23-11-12-24-29/h3-6,9-12,14,16H,7-8,13H2,1-2H3/t14-,16-/m1/s1 CYSKASVYURZNFQ-GDBMZVCRSA-N 426489 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-2-methyl-5-((2-methyl-[1,2,4]triazolo[1,5-c]pyrimidin-5-yl)oxy)piperidin-1-yl)methanone::US10526336, Example 104::US10526336, Example 105 Orexin/Hypocretin receptor type 1 Homo sapiens 7261 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426489&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439342 434320820 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 859979 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cccn2c1nn(C)c2=O InChI=1S/C22H23N7O3/c1-15-9-10-16(32-19-8-5-13-27-20(19)25-26(2)22(27)31)14-28(15)21(30)17-6-3-4-7-18(17)29-23-11-12-24-29/h3-8,11-13,15-16H,9-10,14H2,1-2H3/t15-,16-/m1/s1 IOSIXLFVMLQDKV-HZPDHXFCSA-N 426491 8-(((3R,6R)-1-(2-(2H-1,2,3-triazol-2-yl)benzoyl)-6-methylpiperidin-3-yl)oxy)-2-methyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one::US10526336, Example 106 Orexin receptor type 2 Homo sapiens 178 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426491&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121439492 434320821 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 859980 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cccn2c1nn(C)c2=O InChI=1S/C22H23N7O3/c1-15-9-10-16(32-19-8-5-13-27-20(19)25-26(2)22(27)31)14-28(15)21(30)17-6-3-4-7-18(17)29-23-11-12-24-29/h3-8,11-13,15-16H,9-10,14H2,1-2H3/t15-,16-/m1/s1 IOSIXLFVMLQDKV-HZPDHXFCSA-N 426491 8-(((3R,6R)-1-(2-(2H-1,2,3-triazol-2-yl)benzoyl)-6-methylpiperidin-3-yl)oxy)-2-methyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one::US10526336, Example 106 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q2PN981J aid1804093 US10526336 Kuduk, SD; Liverton, N; Beshore, DC; Meng, N; Luo, Y 1/7/2020 10/25/2020 Merck, Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=426491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=426491&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121439492 434320821 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6